Birc5 | Mouse | (+)-Tetrandrine | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | tetrandrine results in decreased expression of BIRC5 mRNA | CTD | PMID:18495333 |
Birc5 | Mouse | (+)-Tetrandrine | affects binding | ISO | BIRC5 (Homo sapiens) | 6480464 | tetrandrine binds to BIRC5 promoter | CTD | PMID:17968851 |
Birc5 | Mouse | (-)-anisomycin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Anisomycin promotes the reaction [(+)-JQ1 compound results in decreased expression of BIRC5 protein] | CTD | PMID:23872705 |
Birc5 | Mouse | (-)-Arctigenin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | arctigenin results in decreased expression of BIRC5 mRNA | CTD | PMID:20510325 |
Birc5 | Mouse | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [epigallocatechin gallate co-treated with leptomycin B] results in decreased expression of BIRC5 mRNA and [epigallocatechin gallate co-treated with leptomycin B] results in decreased expression of BIRC5 protein | CTD | PMID:25922640 |
Birc5 | Mouse | (-)-gambogic acid | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [gambogic acid co-treated with Doxorubicin] affects the expression of BIRC5 protein and SB 203580 affects the reaction [[gambogic acid co-treated with Doxorubicin] affects the expression of BIRC5 protein] | CTD | PMID:25824409 |
Birc5 | Mouse | (-)-gambogic acid | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | gambogic acid affects the expression of BIRC5 protein | CTD | PMID:25824409 |
Birc5 | Mouse | (-)-noscapine | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Noscapine results in decreased expression of BIRC5 protein | CTD | PMID:20674069 |
Birc5 | Mouse | (-)-noscapine | decreases response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein results in decreased susceptibility to Noscapine | CTD | PMID:22848370 |
Birc5 | Mouse | (-)-noscapine | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Noscapine promotes the reaction [Cisplatin results in decreased expression of BIRC5 protein] | CTD | PMID:20674069 |
Birc5 | Mouse | (-)-noscapine | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Noscapine results in increased expression of BIRC5 mRNA and Noscapine results in increased expression of BIRC5 protein | CTD | PMID:22848370 |
Birc5 | Mouse | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BIRC5 mRNA | CTD | PMID:36331819 |
Birc5 | Mouse | (20R)-protopanaxadiol | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | protopanaxadiol affects the expression of BIRC5 protein | CTD | PMID:31805304 |
Birc5 | Mouse | (20S)-ginsenoside Rg3 | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | ginsenoside Rg3 results in decreased expression of BIRC5 mRNA and ginsenoside Rg3 results in decreased expression of BIRC5 protein | CTD | PMID:19778801 |
Birc5 | Mouse | (S)-naringenin | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | naringenin metabolite results in increased expression of BIRC5 mRNA | CTD | PMID:36235125 |
Birc5 | Mouse | (S)-naringenin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [naringenin co-treated with bisphenol A] results in increased expression of BIRC5 mRNA and [naringenin metabolite co-treated with bisphenol A] results in increased expression of BIRC5 mRNA | CTD | PMID:36235125 |
Birc5 | Mouse | (S)-nicotine | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Nicotine results in increased expression of BIRC5 mRNA and Nicotine results in increased expression of BIRC5 protein | CTD | PMID:16601104 more ... |
Birc5 | Mouse | (S)-nicotine | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Curcumin inhibits the reaction [Nicotine results in increased expression of BIRC5 protein] more ... | CTD | PMID:16601104 and PMID:20727180 |
Birc5 | Mouse | 1'-acetoxychavicol acetate | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of BIRC5 protein] | CTD | PMID:15905586 |
Birc5 | Mouse | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | o and p'-DDT analog results in decreased expression of BIRC5 mRNA | CTD | PMID:22937105 |
Birc5 | Mouse | 1,1-dichloroethene | increases expression | EXP | | 6480464 | vinylidene chloride results in increased expression of BIRC5 mRNA | CTD | PMID:26682919 |
Birc5 | Mouse | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BIRC5 mRNA | CTD | PMID:22206623 |
Birc5 | Mouse | 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Citalopram results in decreased expression of BIRC5 mRNA | CTD | PMID:28467792 |
Birc5 | Mouse | 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Citalopram results in decreased expression of BIRC5 mRNA | CTD | PMID:28467792 |
Birc5 | Mouse | 1-monopalmitoylglycerol | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | palmitoyl glycerol results in decreased expression of BIRC5 protein | CTD | PMID:37466199 |
Birc5 | Mouse | 1-naphthyl isothiocyanate | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of BIRC5 mRNA | CTD | PMID:30723492 |
Birc5 | Mouse | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BIRC5 mRNA | CTD | PMID:17942748 |
Birc5 | Mouse | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of BIRC5 mRNA | CTD | PMID:17555576 |
Birc5 | Mouse | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of BIRC5 mRNA | CTD | PMID:17942748 |
Birc5 | Mouse | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of BIRC5 mRNA | CTD | PMID:25210133 |
Birc5 | Mouse | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of BIRC5 mRNA | CTD | PMID:39298647 |
Birc5 | Mouse | 17beta-estradiol | affects expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Estradiol affects the expression of BIRC5 mRNA | CTD | PMID:32145629 |
Birc5 | Mouse | 17beta-estradiol | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of BIRC5 mRNA | CTD | PMID:21980073 |
Birc5 | Mouse | 17beta-estradiol | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Estradiol affects the expression of BIRC5 mRNA | CTD | PMID:21826169 |
Birc5 | Mouse | 17beta-estradiol | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3 more ... | CTD | PMID:19426747 and PMID:33484789 |
Birc5 | Mouse | 17beta-estradiol | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of BIRC5 mRNA | CTD | PMID:19426747 |
Birc5 | Mouse | 17beta-estradiol | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Estradiol results in increased expression of BIRC5 mRNA and Estradiol results in increased expression of BIRC5 protein | CTD | PMID:16474171 more ... |
Birc5 | Mouse | 17beta-estradiol | multiple interactions | EXP | | 6480464 | ESR1 protein promotes the reaction [Estradiol results in increased expression of BIRC5 mRNA] | CTD | PMID:25210133 |
Birc5 | Mouse | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 |
Birc5 | Mouse | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 |
Birc5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BIRC5 mRNA and AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of BIRC5 mRNA] | CTD | PMID:15034205 and PMID:17942748 |
Birc5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of BIRC5 mRNA | CTD | PMID:34747641 |
Birc5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BIRC5 mRNA and Tetrachlorodibenzodioxin results in increased expression of BIRC5 protein | CTD | PMID:19520675 and PMID:25843524 |
Birc5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BIRC5 mRNA | CTD | PMID:15034205 |
Birc5 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of BIRC5 mRNA | CTD | PMID:21570461 |
Birc5 | Mouse | 2,3-dimethoxynaphthalene-1,4-dione | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:19031421 |
Birc5 | Mouse | 2,4-diaminotoluene | increases expression | EXP | | 6480464 | 2 and 4-diaminotoluene results in increased expression of BIRC5 mRNA | CTD | PMID:20713471 |
Birc5 | Mouse | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | EXP | | 6480464 | 2 more ... | CTD | PMID:38648751 |
Birc5 | Mouse | 2,4-Dihydroxychalcone | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | 2' and 4'-dihydroxychalcone results in decreased expression of BIRC5 mRNA | CTD | PMID:20471467 |
Birc5 | Mouse | 2,5-dimethylcelecoxib | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | 2 and 5-dimethylcelecoxib results in decreased expression of BIRC5 protein | CTD | PMID:16123214 and PMID:16707021 |
Birc5 | Mouse | 2-acetamidofluorene | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | 2-Acetylaminofluorene results in increased expression of BIRC5 mRNA | CTD | PMID:19167416 and PMID:22213190 |
Birc5 | Mouse | 2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | anacardic acid inhibits the reaction [TNF protein results in increased expression of BIRC5 protein] | CTD | PMID:18349320 |
Birc5 | Mouse | 2-methoxyethanol | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | methyl cellosolve results in decreased expression of BIRC5 mRNA | CTD | PMID:19643169 |
Birc5 | Mouse | 2-methylcholine | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of BIRC5 mRNA | CTD | PMID:21179406 |
Birc5 | Mouse | 2-trans,6-trans,10-trans-geranylgeranyl diphosphate | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in decreased expression of BIRC5 protein] | CTD | PMID:17472962 |
Birc5 | Mouse | 2-trans,6-trans-farnesyl diphosphate | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | farnesyl pyrophosphate inhibits the reaction [Lovastatin results in decreased expression of BIRC5 protein] | CTD | PMID:17472962 |
Birc5 | Mouse | 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Puromycin Aminonucleoside results in increased expression of BIRC5 mRNA and Puromycin Aminonucleoside results in increased expression of BIRC5 protein | CTD | PMID:19617259 |
Birc5 | Mouse | 3,3',5,5'-tetrabromobisphenol A | affects expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | tetrabromobisphenol A affects the expression of BIRC5 mRNA | CTD | PMID:26988606 |
Birc5 | Mouse | 3,3'-diindolylmethane | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | 3 and 3'-diindolylmethane results in decreased expression of BIRC5 protein | CTD | PMID:22290291 |
Birc5 | Mouse | 3-iodobenzyl-5'-N-methylcarboxamidoadenosine | decreases response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein results in decreased susceptibility to N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine | CTD | PMID:16088125 |
Birc5 | Mouse | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BIRC5 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BIRC5 mRNA | CTD | PMID:28628672 |
Birc5 | Mouse | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | 2 more ... | CTD | PMID:29704545 |
Birc5 | Mouse | 3-methyladenine | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 3-methyladenine inhibits the reaction [sepantronium results in decreased expression of BIRC5 protein] | CTD | PMID:31837377 |
Birc5 | Mouse | 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of BIRC5 mRNA | CTD | PMID:20713471 |
Birc5 | Mouse | 4'-epidoxorubicin | decreases response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein results in decreased susceptibility to Epirubicin | CTD | PMID:16188142 |
Birc5 | Mouse | 4'-epidoxorubicin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Gossypol results in decreased phosphorylation of EIF4EBP1 protein] inhibits the reaction [Epirubicin results in increased expression of BIRC5 protein] more ... | CTD | PMID:35872041 |
Birc5 | Mouse | 4'-epidoxorubicin | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Epirubicin results in increased expression of BIRC5 protein | CTD | PMID:35872041 |
Birc5 | Mouse | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of BIRC5 mRNA | CTD | PMID:18648102 |
Birc5 | Mouse | 4,4'-sulfonyldiphenol | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of BIRC5 mRNA | CTD | PMID:27685785 and PMID:33312107 |
Birc5 | Mouse | 4,4'-sulfonyldiphenol | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BIRC5 mRNA | CTD | PMID:28628672 |
Birc5 | Mouse | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | decreases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of BIRC5 mRNA | CTD | PMID:21167638 |
Birc5 | Mouse | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone affects the localization of and results in increased expression of BIRC5 protein | CTD | PMID:21776270 |
Birc5 | Mouse | 4-hydroxynon-2-enal | increases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in increased expression of BIRC5 mRNA | CTD | PMID:19191707 |
Birc5 | Mouse | 4-hydroxynon-2-enal | decreases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of BIRC5 mRNA | CTD | PMID:19191707 |
Birc5 | Mouse | 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of BIRC5 mRNA | CTD | PMID:28973697 |
Birc5 | Mouse | 4-phenylbutyric acid | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | 4-phenylbutyric acid results in decreased expression of BIRC5 mRNA | CTD | PMID:30481203 |
Birc5 | Mouse | 5-aza-2'-deoxycytidine | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Decitabine affects the expression of BIRC5 protein | CTD | PMID:18636160 |
Birc5 | Mouse | 5-aza-2'-deoxycytidine | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Decitabine results in decreased expression of BIRC5 mRNA and Decitabine results in decreased expression of BIRC5 protein | CTD | PMID:19363521 |
Birc5 | Mouse | 5-aza-2'-deoxycytidine | decreases methylation | ISO | BIRC5 (Homo sapiens) | 6480464 | Decitabine results in decreased methylation of BIRC5 promoter | CTD | PMID:19363521 |
Birc5 | Mouse | 5-aza-2'-deoxycytidine | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Decitabine inhibits the reaction [trichostatin A results in decreased expression of BIRC5 mRNA] more ... | CTD | PMID:18718068 and PMID:19363521 |
Birc5 | Mouse | 5-bromo-2'-deoxyuridine | multiple interactions | EXP | | 6480464 | [Bromodeoxyuridine co-treated with furan] results in increased expression of BIRC5 mRNA | CTD | PMID:24910943 |
Birc5 | Mouse | 5-fluorouracil | decreases response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein results in decreased susceptibility to Fluorouracil and BIRC5 results in decreased susceptibility to Fluorouracil | CTD | PMID:15685548 more ... |
Birc5 | Mouse | 5-fluorouracil | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Fluorouracil results in increased expression of BIRC5 mRNA and Fluorouracil results in increased expression of BIRC5 protein | CTD | PMID:15109396 more ... |
Birc5 | Mouse | 5-fluorouracil | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Fluorouracil results in decreased expression of BIRC5 mRNA and Fluorouracil results in decreased expression of BIRC5 protein | CTD | PMID:16709241 more ... |
Birc5 | Mouse | 5-fluorouracil | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Fluorouracil co-treated with RNF34 protein] results in increased expression of BIRC5 protein more ... | CTD | PMID:16596200 more ... |
Birc5 | Mouse | 5-fluorouracil | affects response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 affects the susceptibility to Fluorouracil and BIRC5 protein affects the susceptibility to Fluorouracil | CTD | PMID:15067352 more ... |
Birc5 | Mouse | 6-propyl-2-thiouracil | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of BIRC5 mRNA | CTD | PMID:24780913 and PMID:30047161 |
Birc5 | Mouse | acetamide | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of BIRC5 mRNA | CTD | PMID:31881176 |
Birc5 | Mouse | acetylleucyl-leucyl-norleucinal | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | acetylleucyl-leucyl-norleucinal inhibits the reaction [Immunologic Factors results in decreased expression of BIRC5 protein] | CTD | PMID:29974605 |
Birc5 | Mouse | acetylsalicylic acid | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Aspirin results in increased expression of BIRC5 mRNA | CTD | PMID:11906190 and PMID:17342322 |
Birc5 | Mouse | acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein] | CTD | PMID:25449198 |
Birc5 | Mouse | acetylsalicylic acid | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Aspirin results in decreased expression of BIRC5 mRNA and Aspirin results in decreased expression of BIRC5 protein | CTD | PMID:17848598 and PMID:18483385 |
Birc5 | Mouse | acetylsalicylic acid | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Aspirin co-treated with TNFSF10 protein] results in decreased expression of BIRC5 protein more ... | CTD | PMID:17848598 and PMID:18483385 |
Birc5 | Mouse | acrylamide | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of BIRC5 mRNA | CTD | PMID:28959563 |
Birc5 | Mouse | aflatoxin B1 | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of BIRC5 protein | CTD | PMID:20106945 |
Birc5 | Mouse | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of BIRC5 mRNA | CTD | PMID:19770486 |
Birc5 | Mouse | all-trans-retinoic acid | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Tretinoin co-treated with Paclitaxel] results in decreased expression of BIRC5 protein more ... | CTD | PMID:16473406 more ... |
Birc5 | Mouse | all-trans-retinoic acid | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of BIRC5 mRNA and Tretinoin results in decreased expression of BIRC5 protein | CTD | PMID:16135400 more ... |
Birc5 | Mouse | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of BIRC5 mRNA | CTD | PMID:17198874 |
Birc5 | Mouse | alvocidib | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | alvocidib results in decreased expression of BIRC5 more ... | CTD | PMID:12517783 and PMID:16820931 |
Birc5 | Mouse | alvocidib | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [alvocidib co-treated with 7-hydroxystaurosporine] results in decreased expression of BIRC5 protein more ... | CTD | PMID:12517802 more ... |
Birc5 | Mouse | amiodarone | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Amiodarone results in decreased expression of BIRC5 protein | CTD | PMID:21224497 |
Birc5 | Mouse | amitrole | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of BIRC5 mRNA | CTD | PMID:30047161 |
Birc5 | Mouse | andrographolide | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | andrographolide results in decreased expression of BIRC5 protein | CTD | PMID:23845849 |
Birc5 | Mouse | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [arsenic trioxide results in decreased expression of BIRC5 protein] more ... | CTD | PMID:16328441 more ... |
Birc5 | Mouse | antimycin A | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Antimycin A results in increased expression of BIRC5 mRNA | CTD | PMID:33512557 |
Birc5 | Mouse | Antrocin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | antrocin results in decreased expression of BIRC5 mRNA and antrocin results in decreased expression of BIRC5 protein | CTD | PMID:21158420 |
Birc5 | Mouse | aprepitant | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Arsenic Trioxide co-treated with Aprepitant] results in decreased expression of BIRC5 mRNA | CTD | PMID:30145367 |
Birc5 | Mouse | arsane | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Arsenic co-treated with Fluorides] results in increased expression of BIRC5 mRNA | CTD | PMID:19962721 |
Birc5 | Mouse | arsane | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BIRC5 protein and Melatonin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BIRC5 protein] | CTD | PMID:38229313 |
Birc5 | Mouse | arsenic atom | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Arsenic co-treated with Fluorides] results in increased expression of BIRC5 mRNA | CTD | PMID:19962721 |
Birc5 | Mouse | arsenic atom | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BIRC5 protein and Melatonin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BIRC5 protein] | CTD | PMID:38229313 |
Birc5 | Mouse | arsenite(3-) | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to BIRC5 mRNA] and XPA protein affects the reaction [arsenite results in decreased expression of BIRC5 mRNA] | CTD | PMID:18585952 and PMID:32406909 |
Birc5 | Mouse | arsenite(3-) | decreases expression | EXP | | 6480464 | arsenite results in decreased expression of BIRC5 mRNA | CTD | PMID:18929588 |
Birc5 | Mouse | arsenite(3-) | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | arsenite results in decreased expression of BIRC5 mRNA | CTD | PMID:18585952 |
Birc5 | Mouse | arsenous acid | multiple interactions | EXP | | 6480464 | Arsenic Trioxide promotes the reaction [Drugs more ... | CTD | PMID:28587418 |
Birc5 | Mouse | arsenous acid | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of BIRC5 more ... | CTD | PMID:16328441 more ... |
Birc5 | Mouse | arsenous acid | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of BIRC5 mRNA and Arsenic Trioxide results in increased expression of BIRC5 protein | CTD | PMID:15587394 more ... |
Birc5 | Mouse | arsenous acid | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Arsenic Trioxide results in decreased expression of BIRC5 protein] more ... | CTD | PMID:16328441 more ... |
Birc5 | Mouse | arsenous acid | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Arsenic Trioxide affects the expression of BIRC5 mRNA | CTD | PMID:18088464 |
Birc5 | Mouse | arsenous acid | affects response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein affects the susceptibility to Arsenic Trioxide | CTD | PMID:20635649 |
Birc5 | Mouse | arsenous acid | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of BIRC5 protein | CTD | PMID:28587418 |
Birc5 | Mouse | arsenous acid | decreases response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:15587394 and PMID:27430728 |
Birc5 | Mouse | atorvastatin calcium | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Atorvastatin results in decreased expression of BIRC5 mRNA and Atorvastatin results in decreased expression of BIRC5 protein | CTD | PMID:17372815 |
Birc5 | Mouse | ATP | increases abundance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein results in increased abundance of Adenosine Triphosphate | CTD | PMID:32497533 |
Birc5 | Mouse | atrazine | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of BIRC5 mRNA | CTD | PMID:22378314 |
Birc5 | Mouse | azadirachtin A | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | azadirachtin results in decreased expression of BIRC5 protein | CTD | PMID:20429769 |
Birc5 | Mouse | azathioprine | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Azathioprine results in decreased expression of BIRC5 mRNA | CTD | PMID:22623647 |
Birc5 | Mouse | Azoxymethane | multiple interactions | EXP | | 6480464 | [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein more ... | CTD | PMID:25449198 |
Birc5 | Mouse | baicalein | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | baicalein results in decreased expression of BIRC5 protein | CTD | PMID:18025287 |
Birc5 | Mouse | baicalein | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | SB 203580 inhibits the reaction [baicalein results in decreased expression of BIRC5 protein] and wortmannin promotes the reaction [baicalein results in decreased expression of BIRC5 protein] | CTD | PMID:18025287 |
Birc5 | Mouse | barium sulfate | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Barium Sulfate results in increased expression of BIRC5 mRNA | CTD | PMID:29463257 |
Birc5 | Mouse | belinostat | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | belinostat results in decreased expression of BIRC5 mRNA | CTD | PMID:19606018 |
Birc5 | Mouse | benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BIRC5 mRNA and AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of BIRC5 mRNA] | CTD | PMID:15034205 and PMID:27858113 |
Birc5 | Mouse | benzo[a]pyrene | increases methylation | ISO | BIRC5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of BIRC5 3' UTR | CTD | PMID:27901495 |
Birc5 | Mouse | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of BIRC5 mRNA | CTD | PMID:21964900 and PMID:26496743 |
Birc5 | Mouse | benzo[a]pyrene | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of BIRC5 mRNA and Benzo(a)pyrene results in decreased expression of BIRC5 protein | CTD | PMID:20064835 more ... |
Birc5 | Mouse | benzo[a]pyrene | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Curcumin inhibits the reaction [Benzo(a)pyrene results in decreased expression of BIRC5 protein] and Vitamin E inhibits the reaction [Benzo(a)pyrene results in decreased expression of BIRC5 protein] | CTD | PMID:24664296 |
Birc5 | Mouse | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of BIRC5 mRNA | CTD | PMID:15034205 more ... |
Birc5 | Mouse | benzo[a]pyrene diol epoxide I | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 |
Birc5 | Mouse | benzo[a]pyrene diol epoxide I | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20382639 |
Birc5 | Mouse | benzo[b]fluoranthene | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | benzo(b)fluoranthene affects the localization of and results in increased expression of BIRC5 protein | CTD | PMID:21776270 |
Birc5 | Mouse | benzo[b]fluoranthene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BIRC5 mRNA | CTD | PMID:27858113 |
Birc5 | Mouse | benzo[b]fluoranthene | increases expression | EXP | | 6480464 | benzo(b)fluoranthene results in increased expression of BIRC5 mRNA | CTD | PMID:26377693 |
Birc5 | Mouse | Benzo[k]fluoranthene | increases expression | EXP | | 6480464 | benzo(k)fluoranthene results in increased expression of BIRC5 mRNA | CTD | PMID:26377693 |
Birc5 | Mouse | benzoic acid | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Benzoic Acid analog inhibits the reaction [STAT3 protein binds to BIRC5 promoter] | CTD | PMID:26088127 |
Birc5 | Mouse | Berbamine | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | berbamine results in decreased expression of BIRC5 mRNA and berbamine results in decreased expression of BIRC5 protein | CTD | PMID:17531122 and PMID:19960011 |
Birc5 | Mouse | Berbamine | affects binding | ISO | BIRC5 (Homo sapiens) | 6480464 | berbamine binds to BIRC5 promoter | CTD | PMID:17968851 |
Birc5 | Mouse | berberine | affects binding | ISO | BIRC5 (Homo sapiens) | 6480464 | Berberine binds to BIRC5 promoter | CTD | PMID:17968851 |
Birc5 | Mouse | beta-lapachone | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | beta-lapachone results in decreased expression of BIRC5 mRNA | CTD | PMID:38218311 |
Birc5 | Mouse | beta-naphthoflavone | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BIRC5 mRNA | CTD | PMID:18164116 |
Birc5 | Mouse | betulin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | betulin analog promotes the reaction [Oxygen deficiency results in decreased expression of BIRC5 protein] | CTD | PMID:26540049 |
Birc5 | Mouse | betulin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | betulin analog results in decreased expression of BIRC5 protein | CTD | PMID:26540049 |
Birc5 | Mouse | betulinic acid | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Betulinic Acid results in increased expression of BIRC5 | CTD | PMID:16077934 |
Birc5 | Mouse | betulinic acid | decreases response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein results in decreased susceptibility to Betulinic Acid | CTD | PMID:16077934 |
Birc5 | Mouse | betulinic acid | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Betulinic Acid results in decreased expression of BIRC5 protein | CTD | PMID:26540049 and PMID:30136359 |
Birc5 | Mouse | betulinic acid | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 4-((3-bromophenyl)amino)-6 more ... | CTD | PMID:16077934 more ... |
Birc5 | Mouse | bexarotene | decreases expression | EXP | | 6480464 | bexarotene results in decreased expression of BIRC5 mRNA | CTD | PMID:17849452 |
Birc5 | Mouse | bexarotene | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | bexarotene results in decreased expression of BIRC5 protein | CTD | PMID:19067706 |
Birc5 | Mouse | bicalutamide | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | bicalutamide results in decreased expression of BIRC5 mRNA | CTD | PMID:15638997 |
Birc5 | Mouse | bis(2-chloroethyl) sulfide | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Mustard Gas results in decreased expression of BIRC5 mRNA | CTD | PMID:25102026 |
Birc5 | Mouse | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of BIRC5 mRNA | CTD | PMID:33754040 |
Birc5 | Mouse | bisphenol A | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | bisphenol A affects the expression of BIRC5 mRNA | CTD | PMID:21826169 and PMID:30903817 |
Birc5 | Mouse | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of BIRC5 mRNA | CTD | PMID:27623287 |
Birc5 | Mouse | bisphenol A | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BIRC5 mRNA more ... | CTD | PMID:28628672 and PMID:36235125 |
Birc5 | Mouse | bisphenol A | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | bisphenol A analog results in decreased expression of BIRC5 mRNA and bisphenol A results in decreased expression of BIRC5 mRNA | CTD | PMID:27979917 more ... |
Birc5 | Mouse | bisphenol A | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of BIRC5 mRNA | CTD | PMID:25181051 |
Birc5 | Mouse | bisphenol A | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of BIRC5 mRNA | CTD | PMID:18180321 and PMID:32145629 |
Birc5 | Mouse | bisphenol A | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of BIRC5 mRNA and bisphenol A results in increased expression of BIRC5 protein | CTD | PMID:16474171 more ... |
Birc5 | Mouse | bisphenol AF | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | bisphenol AF results in decreased expression of BIRC5 mRNA | CTD | PMID:39059691 |
Birc5 | Mouse | Bisphenol B | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | bisphenol B results in decreased expression of BIRC5 mRNA | CTD | PMID:32387340 |
Birc5 | Mouse | bleomycin A2 | increases expression | EXP | | 6480464 | Bleomycin results in increased expression of BIRC5 mRNA | CTD | PMID:26345256 |
Birc5 | Mouse | bortezomib | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Bortezomib results in increased expression of BIRC5 protein | CTD | PMID:17510429 |
Birc5 | Mouse | bortezomib | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Bortezomib results in decreased expression of BIRC5 mRNA and Bortezomib results in decreased expression of BIRC5 protein | CTD | PMID:17898295 more ... |
Birc5 | Mouse | bortezomib | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Irinotecan co-treated with Bortezomib] results in decreased expression of BIRC5 protein more ... | CTD | PMID:16373703 more ... |
Birc5 | Mouse | budesonide | decreases expression | EXP | | 6480464 | Budesonide results in decreased expression of BIRC5 mRNA | CTD | PMID:17163412 |
Birc5 | Mouse | buta-1,3-diene | increases expression | EXP | | 6480464 | 1 and 3-butadiene results in increased expression of BIRC5 mRNA | CTD | PMID:29038090 |
Birc5 | Mouse | butan-1-ol | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BIRC5 mRNA | CTD | PMID:29432896 |
Birc5 | Mouse | calcitriol | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Arsenic Trioxide co-treated with Calcitriol] results in decreased expression of BIRC5 mRNA more ... | CTD | PMID:21592394 and PMID:34025784 |
Birc5 | Mouse | calcitriol | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of BIRC5 mRNA | CTD | PMID:21592394 |
Birc5 | Mouse | camptothecin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Butyrates co-treated with Camptothecin] results in decreased expression of BIRC5 protein and [Folic Acid co-treated with Camptothecin] results in decreased expression of BIRC5 mRNA | CTD | PMID:16061681 and PMID:30581319 |
Birc5 | Mouse | camptothecin | multiple interactions | EXP | | 6480464 | Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein] | CTD | PMID:25449198 |
Birc5 | Mouse | camptothecin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Camptothecin results in decreased expression of BIRC5 mRNA | CTD | PMID:24726431 and PMID:30581319 |
Birc5 | Mouse | camptothecin | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Camptothecin results in increased expression of BIRC5 mRNA | CTD | PMID:24726431 |
Birc5 | Mouse | cannabidiol | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Cannabidiol co-treated with moringin] results in increased expression of BIRC5 mRNA | CTD | PMID:30096889 |
Birc5 | Mouse | cantharidin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Cantharidin results in decreased expression of BIRC5 protein | CTD | PMID:16117893 |
Birc5 | Mouse | capillarisin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | capillarisin results in decreased expression of BIRC5 mRNA and capillarisin results in decreased expression of BIRC5 protein | CTD | PMID:24333736 |
Birc5 | Mouse | capillarisin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Bortezomib promotes the reaction [capillarisin results in decreased expression of BIRC5 protein] | CTD | PMID:24333736 |
Birc5 | Mouse | capsaicin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Capsaicin results in decreased expression of BIRC5 protein] and BIRC5 results in decreased activity of [Capsaicin co-treated with TNFSF10 protein] | CTD | PMID:19939880 |
Birc5 | Mouse | capsaicin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Capsaicin results in decreased expression of BIRC5 and Capsaicin results in decreased expression of BIRC5 protein | CTD | PMID:17505005 more ... |
Birc5 | Mouse | carbon nanotube | affects expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 |
Birc5 | Mouse | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes and Carbon results in decreased expression of BIRC5 mRNA | CTD | PMID:25620056 |
Birc5 | Mouse | carboxy-PTIO | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:35985571 |
Birc5 | Mouse | celastrol | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | celastrol results in decreased expression of BIRC5 mRNA | CTD | PMID:17010675 |
Birc5 | Mouse | celecoxib | multiple interactions | EXP | | 6480464 | [Celecoxib results in decreased activity of PTGS2 protein] which results in decreased expression of BIRC5 protein | CTD | PMID:21268125 |
Birc5 | Mouse | celecoxib | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Celecoxib results in increased expression of BIRC5 mRNA | CTD | PMID:17342322 |
Birc5 | Mouse | celecoxib | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Celecoxib results in decreased expression of BIRC5 mRNA and Celecoxib results in decreased expression of BIRC5 protein | CTD | PMID:16004971 more ... |
Birc5 | Mouse | celecoxib | affects binding | ISO | BIRC5 (Homo sapiens) | 6480464 | Celecoxib binds to BIRC5 promoter | CTD | PMID:17466271 |
Birc5 | Mouse | celecoxib | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Celecoxib binds to BIRC5 promoter] which results in decreased expression of BIRC5 mRNA and BIRC5 protein inhibits the reaction [Celecoxib results in increased activity of CASP3 protein] | CTD | PMID:17466271 |
Birc5 | Mouse | ceric oxide | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | ceric oxide results in increased expression of BIRC5 mRNA | CTD | PMID:29463257 |
Birc5 | Mouse | chlorambucil | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Chlorambucil affects the expression of BIRC5 mRNA | CTD | PMID:17476690 |
Birc5 | Mouse | chlorambucil | decreases expression | EXP | | 6480464 | Chlorambucil results in decreased expression of BIRC5 protein | CTD | PMID:22025197 |
Birc5 | Mouse | chloroquine | multiple interactions | EXP | | 6480464 | Chloroquine promotes the reaction [sunitinib results in decreased expression of BIRC5 protein] | CTD | PMID:24751611 |
Birc5 | Mouse | chloroquine | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Chloroquine promotes the reaction [Immunologic Factors results in decreased expression of BIRC5 protein] | CTD | PMID:27823620 |
Birc5 | Mouse | chlorpromazine | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Chlorpromazine analog results in decreased expression of BIRC5 mRNA and Chlorpromazine results in decreased expression of BIRC5 mRNA | CTD | PMID:15924885 and PMID:30703373 |
Birc5 | Mouse | chromium(6+) | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of BIRC5 mRNA | CTD | PMID:38479592 |
Birc5 | Mouse | chrysazin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | danthron results in decreased expression of BIRC5 protein | CTD | PMID:21126053 |
Birc5 | Mouse | chrysene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BIRC5 mRNA | CTD | PMID:27858113 |
Birc5 | Mouse | ciclopirox | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | ciclopirox results in decreased expression of BIRC5 mRNA and ciclopirox results in decreased expression of BIRC5 protein | CTD | PMID:19589922 |
Birc5 | Mouse | ciglitazone | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | ciglitazone results in decreased expression of BIRC5 | CTD | PMID:17940898 |
Birc5 | Mouse | Cinobufagin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | cinobufagin results in decreased expression of BIRC5 protein | CTD | PMID:23164673 |
Birc5 | Mouse | Cirsimarin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | cirsimarin results in decreased expression of BIRC5 mRNA | CTD | PMID:35710092 |
Birc5 | Mouse | cisplatin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Cisplatin co-treated with fisetin] results in decreased expression of BIRC5 protein more ... | CTD | PMID:15917659 more ... |
Birc5 | Mouse | cisplatin | decreases response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein results in decreased susceptibility to Cisplatin | CTD | PMID:11911975 more ... |
Birc5 | Mouse | cisplatin | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of BIRC5 mRNA and Cisplatin results in increased expression of BIRC5 protein | CTD | PMID:14988404 more ... |
Birc5 | Mouse | cisplatin | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Cisplatin results in increased expression of BIRC5 mRNA | CTD | PMID:20514400 |
Birc5 | Mouse | cisplatin | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cisplatin results in increased expression of BIRC5 mRNA] | CTD | PMID:20514400 |
Birc5 | Mouse | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of BIRC5 mRNA | CTD | PMID:21151649 |
Birc5 | Mouse | cisplatin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of BIRC5 mRNA and Cisplatin results in decreased expression of BIRC5 protein | CTD | PMID:11911975 more ... |
Birc5 | Mouse | citalopram | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Citalopram results in decreased expression of BIRC5 mRNA | CTD | PMID:28467792 |
Birc5 | Mouse | citalopram | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Citalopram results in decreased expression of BIRC5 mRNA | CTD | PMID:28467792 |
Birc5 | Mouse | cobalt dichloride | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of BIRC5 mRNA | CTD | PMID:19320972 and PMID:19376846 |
Birc5 | Mouse | copper atom | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in decreased expression of BIRC5 mRNA and [NSC 689534 binds to Copper] which results in decreased expression of BIRC5 mRNA | CTD | PMID:20971185 and PMID:30911355 |
Birc5 | Mouse | copper(0) | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in decreased expression of BIRC5 mRNA and [NSC 689534 binds to Copper] which results in decreased expression of BIRC5 mRNA | CTD | PMID:20971185 and PMID:30911355 |
Birc5 | Mouse | copper(II) sulfate | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of BIRC5 mRNA | CTD | PMID:19549813 |
Birc5 | Mouse | cordycepin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | cordycepin results in decreased expression of BIRC5 protein | CTD | PMID:33948356 |
Birc5 | Mouse | corosolic acid | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | corosolic acid results in increased expression of BIRC5 protein | CTD | PMID:28506699 |
Birc5 | Mouse | coumarin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | coumarin analog results in decreased expression of BIRC5 mRNA | CTD | PMID:32578917 |
Birc5 | Mouse | coumarins | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Coumarins analog results in decreased expression of BIRC5 protein | CTD | PMID:25231984 |
Birc5 | Mouse | coumestrol | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 |
Birc5 | Mouse | coumestrol | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of BIRC5 mRNA | CTD | PMID:19167446 |
Birc5 | Mouse | crizotinib | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | crizotinib results in decreased expression of BIRC5 protein | CTD | PMID:22729845 |
Birc5 | Mouse | crizotinib | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | MET gene mutant form promotes the reaction [crizotinib results in increased expression of BIRC5 protein] | CTD | PMID:22729845 |
Birc5 | Mouse | crocin-1 | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | crocin results in decreased expression of BIRC5 mRNA | CTD | PMID:32886819 |
Birc5 | Mouse | curcumin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Arsenic Trioxide co-treated with Curcumin] results in decreased expression of BIRC5 protein more ... | CTD | PMID:20727180 more ... |
Birc5 | Mouse | curcumin | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | Curcumin inhibits the reaction [Doxorubicin results in decreased expression of BIRC5 protein] | CTD | PMID:34047412 |
Birc5 | Mouse | curcumin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Curcumin analog results in decreased expression of BIRC5 mRNA more ... | CTD | PMID:16023083 more ... |
Birc5 | Mouse | curcumin | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with Gemcitabine] results in decreased expression of BIRC5 protein | CTD | PMID:17440100 |
Birc5 | Mouse | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of BIRC5 mRNA | CTD | PMID:17942131 |
Birc5 | Mouse | cyclosporin A | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of BIRC5 mRNA | CTD | PMID:20106945 more ... |
Birc5 | Mouse | dacarbazine | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Dacarbazine results in increased expression of BIRC5 protein | CTD | PMID:15577328 |
Birc5 | Mouse | dactolisib | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | dactolisib results in decreased expression of BIRC5 protein | CTD | PMID:22729845 |
Birc5 | Mouse | daunorubicin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [bromotetrandrine co-treated with Daunorubicin] results in decreased expression of BIRC5 mRNA more ... | CTD | PMID:21362215 and PMID:21720514 |
Birc5 | Mouse | daunorubicin | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Daunorubicin affects the expression of BIRC5 mRNA | CTD | PMID:16638212 |
Birc5 | Mouse | daunorubicin | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Daunorubicin results in increased expression of BIRC5 mRNA and Daunorubicin results in increased expression of BIRC5 protein | CTD | PMID:16638212 and PMID:27780733 |
Birc5 | Mouse | DDE | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of BIRC5 mRNA | CTD | PMID:38568856 |
Birc5 | Mouse | decabromodiphenyl ether | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | decabromobiphenyl ether results in decreased expression of BIRC5 mRNA | CTD | PMID:26206603 |
Birc5 | Mouse | deguelin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | deguelin inhibits the reaction [docetaxel results in increased expression of BIRC5 protein] and deguelin inhibits the reaction [Doxorubicin results in increased expression of BIRC5 protein] | CTD | PMID:17035597 |
Birc5 | Mouse | deguelin | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | deguelin results in increased expression of BIRC5 mRNA | CTD | PMID:33512557 |
Birc5 | Mouse | deguelin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | deguelin results in decreased expression of BIRC5 protein | CTD | PMID:17035597 more ... |
Birc5 | Mouse | demethoxycurcumin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | demethoxycurcumin results in decreased expression of BIRC5 protein | CTD | PMID:34291863 |
Birc5 | Mouse | Destruxin B | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | destruxin B results in decreased expression of BIRC5 protein | CTD | PMID:22465936 and PMID:24434019 |
Birc5 | Mouse | dexamethasone | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Dexamethasone affects the expression of BIRC5 | CTD | PMID:21244764 |
Birc5 | Mouse | dexamethasone | multiple interactions | EXP | | 6480464 | 2 more ... | CTD | PMID:29704545 |
Birc5 | Mouse | dexamethasone | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BIRC5 mRNA more ... | CTD | PMID:20693715 more ... |
Birc5 | Mouse | dextran sulfate | multiple interactions | EXP | | 6480464 | [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein more ... | CTD | PMID:25449198 |
Birc5 | Mouse | diallyl disulfide | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | diallyl disulfide results in decreased expression of BIRC5 protein | CTD | PMID:17647244 |
Birc5 | Mouse | Diallyl sulfide | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | allyl sulfide results in decreased expression of BIRC5 protein | CTD | PMID:17647244 |
Birc5 | Mouse | diallyl trisulfide | increases expression | EXP | | 6480464 | diallyl trisulfide results in increased expression of BIRC5 protein | CTD | PMID:21411500 |
Birc5 | Mouse | diallyl trisulfide | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | diallyl trisulfide results in decreased expression of BIRC5 mRNA and diallyl trisulfide results in decreased expression of BIRC5 protein | CTD | PMID:23754639 and PMID:34995734 |
Birc5 | Mouse | diallyl trisulfide | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | diallyl trisulfide results in increased expression of BIRC5 mRNA and diallyl trisulfide results in increased expression of BIRC5 protein | CTD | PMID:21411500 |
Birc5 | Mouse | diarsenic trioxide | decreases expression | EXP | | 6480464 | Arsenic Trioxide results in decreased expression of BIRC5 protein | CTD | PMID:28587418 |
Birc5 | Mouse | diarsenic trioxide | decreases response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:15587394 and PMID:27430728 |
Birc5 | Mouse | diarsenic trioxide | multiple interactions | EXP | | 6480464 | Arsenic Trioxide promotes the reaction [Drugs more ... | CTD | PMID:28587418 |
Birc5 | Mouse | diarsenic trioxide | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Arsenic Trioxide affects the expression of BIRC5 mRNA | CTD | PMID:18088464 |
Birc5 | Mouse | diarsenic trioxide | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of BIRC5 more ... | CTD | PMID:16328441 more ... |
Birc5 | Mouse | diarsenic trioxide | affects response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein affects the susceptibility to Arsenic Trioxide | CTD | PMID:20635649 |
Birc5 | Mouse | diarsenic trioxide | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Arsenic Trioxide results in decreased expression of BIRC5 protein] more ... | CTD | PMID:16328441 more ... |
Birc5 | Mouse | diarsenic trioxide | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of BIRC5 mRNA and Arsenic Trioxide results in increased expression of BIRC5 protein | CTD | PMID:15587394 more ... |
Birc5 | Mouse | diazene | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | diazene analog affects the expression of BIRC5 | CTD | PMID:16061352 |
Birc5 | Mouse | diazinon | affects expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Diazinon affects the expression of BIRC5 mRNA | CTD | PMID:22546817 |
Birc5 | Mouse | diazinon | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA] more ... | CTD | PMID:27920530 |
Birc5 | Mouse | diazinon | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Diazinon results in decreased expression of BIRC5 mRNA | CTD | PMID:27920530 |
Birc5 | Mouse | dibenz[a,h]anthracene | increases expression | EXP | | 6480464 | 1 more ... | CTD | PMID:26377693 |
Birc5 | Mouse | dibenzo[a,l]pyrene | decreases expression | EXP | | 6480464 | dibenzo(a and l)pyrene results in decreased expression of BIRC5 mRNA | CTD | PMID:26496743 |
Birc5 | Mouse | Dibutyl phosphate | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of BIRC5 mRNA | CTD | PMID:37042841 |
Birc5 | Mouse | dibutyl phthalate | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in decreased expression of BIRC5 mRNA | CTD | PMID:21266533 |
Birc5 | Mouse | dibutyl phthalate | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Dibutyl Phthalate results in increased expression of BIRC5 mRNA | CTD | PMID:36828243 |
Birc5 | Mouse | dibutyl phthalate | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | N-methyl-delta-3 more ... | CTD | PMID:36828243 |
Birc5 | Mouse | dibutyl phthalate | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Dibutyl Phthalate results in decreased expression of BIRC5 mRNA | CTD | PMID:28973377 |
Birc5 | Mouse | dibutyl phthalate | multiple interactions | EXP | | 6480464 | Nimodipine inhibits the reaction [Dibutyl Phthalate results in decreased expression of BIRC5 protein] | CTD | PMID:33336902 |
Birc5 | Mouse | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of BIRC5 mRNA and Dibutyl Phthalate results in decreased expression of BIRC5 protein | CTD | PMID:17361019 and PMID:33336902 |
Birc5 | Mouse | dibutyl phthalate | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Dibutyl Phthalate results in increased expression of BIRC5 mRNA | CTD | PMID:17379624 |
Birc5 | Mouse | dichloroacetic acid | increases expression | EXP | | 6480464 | Dichloroacetic Acid results in increased expression of BIRC5 mRNA | CTD | PMID:28962523 |
Birc5 | Mouse | dieldrin | affects expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Dieldrin affects the expression of BIRC5 mRNA | CTD | PMID:22546817 |
Birc5 | Mouse | diethylstilbestrol | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Diethylstilbestrol results in increased expression of BIRC5 mRNA | CTD | PMID:37077353 |
Birc5 | Mouse | digitoxin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Digitoxin analog results in decreased expression of BIRC5 protein and Digitoxin results in decreased expression of BIRC5 protein | CTD | PMID:22037315 |
Birc5 | Mouse | dimethylarsinic acid | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Cacodylic Acid results in increased expression of BIRC5 mRNA and Cacodylic Acid results in increased expression of BIRC5 protein | CTD | PMID:32474354 |
Birc5 | Mouse | dimethylarsinic acid | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | Cacodylic Acid inhibits the reaction [sodium arsenite results in increased expression of BIRC5 protein] more ... | CTD | PMID:32474354 |
Birc5 | Mouse | dimethylarsinic acid | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Cacodylic Acid results in increased expression of BIRC5 protein | CTD | PMID:32474354 |
Birc5 | Mouse | dioscin | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | dioscin results in increased expression of BIRC5 mRNA | CTD | PMID:29990575 |
Birc5 | Mouse | dioxygen | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 3 more ... | CTD | PMID:16628086 more ... |
Birc5 | Mouse | dioxygen | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of BIRC5 protein and Oxygen results in decreased expression of BIRC5 mRNA | CTD | PMID:26540049 and PMID:27103661 |
Birc5 | Mouse | dioxygen | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of BIRC5 mRNA and Oxygen deficiency results in increased expression of BIRC5 protein | CTD | PMID:23452621 |
Birc5 | Mouse | disulfiram | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Disulfiram results in increased expression of BIRC5 protein | CTD | PMID:34182011 |
Birc5 | Mouse | dorsomorphin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BIRC5 mRNA | CTD | PMID:27188386 |
Birc5 | Mouse | doxorubicin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Arsenic Trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BIRC5 mRNA more ... | CTD | PMID:12517802 more ... |
Birc5 | Mouse | doxorubicin | multiple interactions | EXP | | 6480464 | Doxorubicin promotes the reaction [thymoquinone results in decreased expression of BIRC5 protein] and thymoquinone promotes the reaction [Doxorubicin results in decreased expression of BIRC5 protein] | CTD | PMID:34605108 |
Birc5 | Mouse | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of BIRC5 protein | CTD | PMID:34605108 |
Birc5 | Mouse | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of BIRC5 mRNA | CTD | PMID:36227756 |
Birc5 | Mouse | doxorubicin | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Doxorubicin results in decreased expression of BIRC5 protein | CTD | PMID:34047412 |
Birc5 | Mouse | doxorubicin | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | Curcumin inhibits the reaction [Doxorubicin results in decreased expression of BIRC5 protein] | CTD | PMID:34047412 |
Birc5 | Mouse | doxorubicin | decreases response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:11911975 more ... |
Birc5 | Mouse | doxorubicin | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of BIRC5 mRNA and Doxorubicin results in increased expression of BIRC5 protein | CTD | PMID:16086872 more ... |
Birc5 | Mouse | doxorubicin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of BIRC5 mRNA more ... | CTD | PMID:11911975 more ... |
Birc5 | Mouse | elemental selenium | affects response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein affects the susceptibility to Selenium | CTD | PMID:17876054 |
Birc5 | Mouse | elemental selenium | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA] and Selenium analog inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA] | CTD | PMID:27920530 |
Birc5 | Mouse | emodin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Emodin results in decreased expression of BIRC5 mRNA and Emodin results in decreased expression of BIRC5 protein | CTD | PMID:23848338 |
Birc5 | Mouse | endosulfan | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Endosulfan results in decreased expression of BIRC5 mRNA | CTD | PMID:26714676 and PMID:30090376 |
Birc5 | Mouse | endosulfan | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Endosulfan results in increased expression of BIRC5 mRNA | CTD | PMID:29705383 |
Birc5 | Mouse | Enterolactone | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BIRC5 mRNA | CTD | PMID:19167446 |
Birc5 | Mouse | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of BIRC5 protein | CTD | PMID:29845424 |
Birc5 | Mouse | enzalutamide | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | enzalutamide promotes the reaction [Niclosamide results in decreased expression of BIRC5 protein] | CTD | PMID:25970160 |
Birc5 | Mouse | enzyme inhibitor | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of APEX1 protein] which results in decreased expression of BIRC5 mRNA and [Enzyme Inhibitors results in decreased activity of APEX1 protein] which results in decreased expression of BIRC5 protein | CTD | PMID:29541389 |
Birc5 | Mouse | epoxomicin | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | epoxomicin results in increased expression of BIRC5 protein | CTD | PMID:17510429 |
Birc5 | Mouse | epoxomicin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | epoxomicin inhibits the reaction [Aspirin results in decreased expression of BIRC5 protein] | CTD | PMID:18483385 |
Birc5 | Mouse | erlotinib hydrochloride | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Erlotinib Hydrochloride co-treated with Arsenic Trioxide] results in decreased expression of BIRC5 mRNA more ... | CTD | PMID:25895606 more ... |
Birc5 | Mouse | erlotinib hydrochloride | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Erlotinib Hydrochloride results in decreased expression of BIRC5 protein | CTD | PMID:25895606 |
Birc5 | Mouse | escitalopram | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Escitalopram results in decreased expression of BIRC5 mRNA | CTD | PMID:28467792 |
Birc5 | Mouse | escitalopram | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Escitalopram results in decreased expression of BIRC5 mRNA | CTD | PMID:28467792 |
Birc5 | Mouse | etacrynic acid | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [arsenic trioxide co-treated with Ethacrynic Acid] results in decreased expression of BIRC5 protein | CTD | PMID:23082001 |
Birc5 | Mouse | ethanol | multiple interactions | EXP | | 6480464 | [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of BIRC5 mRNA | CTD | PMID:30517762 |
Birc5 | Mouse | etodolac | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Etodolac results in decreased expression of BIRC5 protein | CTD | PMID:16004971 and PMID:16104877 |
Birc5 | Mouse | etodolac | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [oxaliplatin co-treated with Etodolac] results in decreased expression of BIRC5 protein | CTD | PMID:16004971 |
Birc5 | Mouse | etodolac | increases activity | ISO | BIRC5 (Homo sapiens) | 6480464 | Etodolac results in increased activity of BIRC5 protein | CTD | PMID:16046235 |
Birc5 | Mouse | etoposide | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [FOXO3 protein results in decreased expression of BIRC5 protein] which results in increased susceptibility to Etoposide more ... | CTD | PMID:15917659 more ... |
Birc5 | Mouse | etoposide | decreases response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein results in decreased susceptibility to Etoposide | CTD | PMID:16322251 more ... |
Birc5 | Mouse | etoposide | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Etoposide results in increased expression of BIRC5 mRNA | CTD | PMID:19426747 |
Birc5 | Mouse | everolimus | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Everolimus results in decreased expression of BIRC5 protein | CTD | PMID:21601561 more ... |
Birc5 | Mouse | everolimus | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Everolimus promotes the reaction [platycodin D results in decreased expression of BIRC5 protein] more ... | CTD | PMID:28711525 and PMID:28947240 |
Birc5 | Mouse | Evodiamine | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | evodiamine inhibits the reaction [TNF protein results in increased expression of BIRC5 protein] more ... | CTD | PMID:15710601 more ... |
Birc5 | Mouse | Evodiamine | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | evodiamine results in decreased expression of BIRC5 mRNA and evodiamine results in decreased expression of BIRC5 protein | CTD | PMID:32057900 and PMID:32183146 |
Birc5 | Mouse | fangchinoline | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | fangchinoline results in decreased expression of BIRC5 mRNA and fangchinoline results in decreased expression of BIRC5 protein | CTD | PMID:28754437 |
Birc5 | Mouse | farnesyl diphosphate | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | farnesyl pyrophosphate inhibits the reaction [Lovastatin results in decreased expression of BIRC5 protein] | CTD | PMID:17472962 |
Birc5 | Mouse | fenhexamid | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | N-(2 and 3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of BIRC5 protein | CTD | PMID:33484789 |
Birc5 | Mouse | fenhexamid | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3 more ... | CTD | PMID:33484789 |
Birc5 | Mouse | fenpyroximate | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | fenpyroximate results in increased expression of BIRC5 mRNA | CTD | PMID:33512557 |
Birc5 | Mouse | fisetin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Cisplatin co-treated with fisetin] results in decreased expression of BIRC5 protein | CTD | PMID:21216935 |
Birc5 | Mouse | flurbiprofen | increases expression | EXP | | 6480464 | Flurbiprofen results in increased expression of BIRC5 mRNA | CTD | PMID:16949054 |
Birc5 | Mouse | folic acid | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BIRC5 mRNA | CTD | PMID:22206623 |
Birc5 | Mouse | folic acid | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Folic Acid results in increased expression of BIRC5 mRNA | CTD | PMID:36354958 |
Birc5 | Mouse | folic acid | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Folic Acid co-treated with Camptothecin] results in decreased expression of BIRC5 mRNA more ... | CTD | PMID:30581319 |
Birc5 | Mouse | folic acid | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Folic Acid deficiency results in decreased expression of BIRC5 protein | CTD | PMID:28639913 |
Birc5 | Mouse | fucoidan | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | fucoidan results in decreased expression of BIRC5 protein | CTD | PMID:16201850 |
Birc5 | Mouse | fucoxanthin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | fucoxanthin results in decreased expression of BIRC5 protein | CTD | PMID:38444163 |
Birc5 | Mouse | fulvestrant | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | fulvestrant results in decreased expression of BIRC5 mRNA | CTD | PMID:21980073 |
Birc5 | Mouse | fulvestrant | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | fulvestrant results in decreased expression of BIRC5 mRNA | CTD | PMID:19016759 |
Birc5 | Mouse | fulvestrant | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3 more ... | CTD | PMID:19016759 and PMID:33484789 |
Birc5 | Mouse | furan | multiple interactions | EXP | | 6480464 | [Bromodeoxyuridine co-treated with furan] results in increased expression of BIRC5 mRNA | CTD | PMID:24910943 |
Birc5 | Mouse | furan | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | furan results in increased expression of BIRC5 mRNA | CTD | PMID:22079235 and PMID:25539665 |
Birc5 | Mouse | furan | increases expression | EXP | | 6480464 | furan results in increased expression of BIRC5 mRNA | CTD | PMID:24183702 and PMID:24910943 |
Birc5 | Mouse | furosemide | affects expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Furosemide affects the expression of BIRC5 mRNA | CTD | PMID:17497460 |
Birc5 | Mouse | gamma-aminobutyric acid | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | gamma-Aminobutyric Acid results in increased expression of BIRC5 mRNA | CTD | PMID:26924987 |
Birc5 | Mouse | gamma-tocopherol | increases expression | EXP | | 6480464 | Tocopherols results in increased expression of BIRC5 mRNA | CTD | PMID:17056531 |
Birc5 | Mouse | gedunin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | gedunin results in decreased expression of BIRC5 mRNA | CTD | PMID:17010675 |
Birc5 | Mouse | gefitinib | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | gefitinib results in increased expression of BIRC5 protein | CTD | PMID:17473213 |
Birc5 | Mouse | gefitinib | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Gefitinib results in decreased expression of BIRC5 protein | CTD | PMID:28942004 and PMID:36807944 |
Birc5 | Mouse | gefitinib | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | leptomycin B promotes the reaction [gefitinib results in decreased expression of BIRC5 protein] and tyrphostin AG 1024 inhibits the reaction [gefitinib results in increased expression of BIRC5 protein] | CTD | PMID:17473213 and PMID:28942004 |
Birc5 | Mouse | gemcitabine | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BIRC5 mRNA] and Gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BIRC5 protein] | CTD | PMID:16929163 |
Birc5 | Mouse | gemcitabine | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Gemcitabine results in decreased expression of BIRC5 protein | CTD | PMID:38000456 |
Birc5 | Mouse | gemcitabine | multiple interactions | EXP | | 6480464 | [Curcumin co-treated with Gemcitabine] results in decreased expression of BIRC5 protein | CTD | PMID:17440100 |
Birc5 | Mouse | genistein | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Genistein results in increased expression of BIRC5 mRNA | CTD | PMID:16474171 |
Birc5 | Mouse | genistein | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Genistein inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein] | CTD | PMID:23452621 |
Birc5 | Mouse | genistein | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Genistein results in decreased expression of BIRC5 mRNA | CTD | PMID:16705744 |
Birc5 | Mouse | gentamycin | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of BIRC5 mRNA | CTD | PMID:33387578 |
Birc5 | Mouse | geraniol | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | geraniol results in decreased expression of BIRC5 mRNA | CTD | PMID:27683099 |
Birc5 | Mouse | gingerol | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [gingerol results in decreased expression of BIRC5 protein] and gingerol inhibits the reaction [Testosterone results in increased expression of BIRC5 protein] | CTD | PMID:18030663 and PMID:25034532 |
Birc5 | Mouse | gingerol | multiple interactions | EXP | | 6480464 | gingerol inhibits the reaction [Testosterone results in increased expression of BIRC5 protein] | CTD | PMID:18030663 |
Birc5 | Mouse | gingerol | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | gingerol results in decreased expression of BIRC5 protein | CTD | PMID:18030663 and PMID:25034532 |
Birc5 | Mouse | glycochenodeoxycholic acid | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Glycochenodeoxycholic Acid results in increased expression of BIRC5 mRNA | CTD | PMID:15767249 |
Birc5 | Mouse | gossypol | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Gossypol results in decreased phosphorylation of EIF4EBP1 protein] inhibits the reaction [Epirubicin results in increased expression of BIRC5 protein] and Gossypol inhibits the reaction [Epirubicin results in increased expression of BIRC5 protein] | CTD | PMID:35872041 |
Birc5 | Mouse | guggulsterone | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | pregna-4 more ... | CTD | PMID:15322087 |
Birc5 | Mouse | Hexamethonium | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Hexamethonium affects the reaction [Nicotine results in increased expression of BIRC5 protein] | CTD | PMID:16601104 |
Birc5 | Mouse | hydrogen peroxide | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of BIRC5 mRNA | CTD | PMID:20044591 and PMID:26519223 |
Birc5 | Mouse | hydrogen peroxide | affects localization | ISO | BIRC5 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the localization of BIRC5 protein | CTD | PMID:28343997 |
Birc5 | Mouse | hydrogen peroxide | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in decreased expression of BIRC5 mRNA | CTD | PMID:33709623 |
Birc5 | Mouse | hydroquinone | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Lithium Chloride inhibits the reaction [hydroquinone results in decreased expression of BIRC5 protein] | CTD | PMID:28886972 |
Birc5 | Mouse | hydroquinone | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | hydroquinone results in decreased expression of BIRC5 protein | CTD | PMID:28886972 |
Birc5 | Mouse | hydroxamic acid | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Hydroxamic Acids analog results in decreased expression of BIRC5 protein | CTD | PMID:26088127 |
Birc5 | Mouse | indole-3-methanol | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BIRC5 protein] | CTD | PMID:15811958 |
Birc5 | Mouse | indole-3-methanol | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | indole-3-carbinol results in decreased expression of BIRC5 | CTD | PMID:16082211 |
Birc5 | Mouse | indometacin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Indomethacin results in decreased expression of BIRC5 mRNA and Indomethacin results in decreased expression of BIRC5 protein | CTD | PMID:15248904 and PMID:17270149 |
Birc5 | Mouse | indometacin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BIRC5 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of BIRC5 mRNA | CTD | PMID:28628672 |
Birc5 | Mouse | indometacin | multiple interactions | EXP | | 6480464 | [Indomethacin results in decreased activity of PTGS2 protein] which results in decreased expression of BIRC5 protein more ... | CTD | PMID:21268125 |
Birc5 | Mouse | indometacin | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Indomethacin results in decreased expression of BIRC5 protein | CTD | PMID:17654042 |
Birc5 | Mouse | indometacin | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | TXN protein inhibits the reaction [Indomethacin results in decreased expression of BIRC5 protein] | CTD | PMID:17654042 |
Birc5 | Mouse | inuviscolide | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | inuviscolide results in decreased expression of BIRC5 protein | CTD | PMID:17919456 |
Birc5 | Mouse | irinotecan | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Irinotecan co-treated with Bortezomib] results in decreased expression of BIRC5 protein and Irinotecan promotes the reaction [AS602868 results in decreased expression of BIRC5 mRNA] | CTD | PMID:16373703 and PMID:18182997 |
Birc5 | Mouse | irinotecan | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Irinotecan metabolite results in decreased expression of BIRC5 mRNA and Irinotecan results in decreased expression of BIRC5 mRNA | CTD | PMID:15956246 |
Birc5 | Mouse | isoflurane | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Isoflurane results in decreased expression of BIRC5 mRNA | CTD | PMID:16978161 |
Birc5 | Mouse | isotretinoin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of BIRC5 protein | CTD | PMID:16135400 |
Birc5 | Mouse | Jatrorrhizine | affects binding | ISO | BIRC5 (Homo sapiens) | 6480464 | jatrorrhizine binds to BIRC5 promoter | CTD | PMID:17968851 |
Birc5 | Mouse | ketoconazole | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Ketoconazole results in increased expression of BIRC5 mRNA | CTD | PMID:37077353 |
Birc5 | Mouse | L-ascorbic acid | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Ascorbic Acid results in decreased expression of BIRC5 mRNA | CTD | PMID:21919647 |
Birc5 | Mouse | lapatinib | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | lapatinib results in decreased expression of BIRC5 protein | CTD | PMID:16091755 |
Birc5 | Mouse | LCL161 | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | LCL161 results in decreased expression of BIRC5 protein | CTD | PMID:32497533 |
Birc5 | Mouse | lead diacetate | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | RBBP4 protein inhibits the reaction [lead acetate results in decreased expression of BIRC5 mRNA] and RBBP4 protein inhibits the reaction [lead acetate results in decreased expression of BIRC5 protein] | CTD | PMID:37866543 |
Birc5 | Mouse | lead diacetate | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | lead acetate results in decreased expression of BIRC5 mRNA and lead acetate results in decreased expression of BIRC5 protein | CTD | PMID:37866543 |
Birc5 | Mouse | leflunomide | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of BIRC5 mRNA | CTD | PMID:28988120 |
Birc5 | Mouse | leptomycin B | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [epigallocatechin gallate co-treated with leptomycin B] results in decreased expression of BIRC5 mRNA more ... | CTD | PMID:20803015 more ... |
Birc5 | Mouse | leptomycin B | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | leptomycin B results in decreased expression of BIRC5 mRNA and leptomycin B results in decreased expression of BIRC5 protein | CTD | PMID:20803015 and PMID:25922640 |
Birc5 | Mouse | Licochalcone A | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | licochalcone A results in decreased expression of BIRC5 mRNA | CTD | PMID:30055311 |
Birc5 | Mouse | Licochalcone B | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | licochalcone B results in decreased expression of BIRC5 protein | CTD | PMID:24384411 |
Birc5 | Mouse | lidocaine | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Lidocaine results in increased expression of BIRC5 mRNA | CTD | PMID:35283115 |
Birc5 | Mouse | lithium atom | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Lithium results in increased expression of BIRC5 mRNA | CTD | PMID:16288908 |
Birc5 | Mouse | lithium chloride | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | Lithium Chloride inhibits the reaction [manganese chloride results in decreased expression of BIRC5 mRNA] | CTD | PMID:24464479 |
Birc5 | Mouse | lithium chloride | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Lithium Chloride results in increased expression of BIRC5 protein | CTD | PMID:35985571 |
Birc5 | Mouse | lithium chloride | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Lithium Chloride inhibits the reaction [hydroquinone results in decreased expression of BIRC5 protein] more ... | CTD | PMID:28886972 and PMID:35985571 |
Birc5 | Mouse | lithium hydride | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Lithium results in increased expression of BIRC5 mRNA | CTD | PMID:16288908 |
Birc5 | Mouse | lonafarnib | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | lonafarnib inhibits the reaction [TNF protein results in increased expression of BIRC5 protein] | CTD | PMID:15090542 |
Birc5 | Mouse | lovastatin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | farnesyl pyrophosphate inhibits the reaction [Lovastatin results in decreased expression of BIRC5 protein] and geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in decreased expression of BIRC5 protein] | CTD | PMID:17472962 |
Birc5 | Mouse | lovastatin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Lovastatin results in decreased expression of BIRC5 protein | CTD | PMID:17472962 and PMID:18815881 |
Birc5 | Mouse | lucanthone | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Lucanthone results in decreased expression of BIRC5 mRNA | CTD | PMID:21148553 |
Birc5 | Mouse | LY294002 | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BIRC5 mRNA and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BIRC5 protein | CTD | PMID:15065019 more ... |
Birc5 | Mouse | LY294002 | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of BIRC5 mRNA | CTD | PMID:22046442 |
Birc5 | Mouse | LY294002 | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cisplatin results in increased expression of BIRC5 mRNA] | CTD | PMID:20514400 |
Birc5 | Mouse | LY294002 | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [CALCA protein results in increased expression of BIRC5 protein] more ... | CTD | PMID:16222118 more ... |
Birc5 | Mouse | magnesium oxide | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA] and Magnesium Oxide analog inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA] | CTD | PMID:27920530 |
Birc5 | Mouse | malathion | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | Rosmarinic Acid inhibits the reaction [Malathion results in increased expression of BIRC5 protein] and thymoquinone inhibits the reaction [Malathion results in increased expression of BIRC5 protein] | CTD | PMID:33510276 and PMID:34262720 |
Birc5 | Mouse | malathion | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Malathion results in increased expression of BIRC5 protein | CTD | PMID:33510276 and PMID:34262720 |
Birc5 | Mouse | manganese(II) chloride | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | Lithium Chloride inhibits the reaction [manganese chloride results in decreased expression of BIRC5 mRNA] | CTD | PMID:24464479 |
Birc5 | Mouse | manganese(II) chloride | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | manganese chloride results in decreased expression of BIRC5 mRNA | CTD | PMID:24464479 |
Birc5 | Mouse | mangiferin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | mangiferin results in decreased expression of BIRC5 protein | CTD | PMID:26996543 |
Birc5 | Mouse | melatonin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Melatonin results in decreased expression of BIRC5 mRNA | CTD | PMID:33507000 |
Birc5 | Mouse | melatonin | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | Melatonin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BIRC5 protein] | CTD | PMID:38229313 |
Birc5 | Mouse | melatonin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Doxorubicin co-treated with Melatonin] results in decreased expression of BIRC5 protein and Doxorubicin promotes the reaction [Melatonin results in decreased expression of BIRC5 mRNA] | CTD | PMID:33507000 |
Birc5 | Mouse | melphalan | affects response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein affects the susceptibility to Melphalan | CTD | PMID:16373717 |
Birc5 | Mouse | melphalan | decreases expression | EXP | | 6480464 | Melphalan results in decreased expression of BIRC5 protein | CTD | PMID:22025197 |
Birc5 | Mouse | melphalan | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Nocodazole affects the reaction [BIRC5 protein affects the susceptibility to Melphalan] and Paclitaxel affects the reaction [BIRC5 protein affects the susceptibility to Melphalan] | CTD | PMID:16373717 |
Birc5 | Mouse | memantine | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Memantine results in decreased expression of BIRC5 protein | CTD | PMID:29226720 |
Birc5 | Mouse | menadione | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of BIRC5 mRNA | CTD | PMID:20044591 |
Birc5 | Mouse | menaquinone | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Vitamin K 2 results in decreased expression of BIRC5 protein | CTD | PMID:29432837 |
Birc5 | Mouse | metformin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Metformin results in decreased expression of BIRC5 protein | CTD | PMID:29226720 |
Birc5 | Mouse | methamphetamine | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Methamphetamine results in decreased expression of BIRC5 mRNA | CTD | PMID:25290377 |
Birc5 | Mouse | methimazole | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Methimazole results in increased expression of BIRC5 mRNA | CTD | PMID:30047161 |
Birc5 | Mouse | methoxsalen | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | BHLHE40 protein inhibits the reaction [Methoxsalen results in decreased expression of BIRC5 protein] | CTD | PMID:22796345 |
Birc5 | Mouse | methoxsalen | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Methoxsalen results in decreased expression of BIRC5 protein | CTD | PMID:22796345 |
Birc5 | Mouse | methyl methanesulfonate | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Folic Acid co-treated with Methyl Methanesulfonate] results in decreased expression of BIRC5 mRNA | CTD | PMID:30581319 |
Birc5 | Mouse | methyl methanesulfonate | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of BIRC5 mRNA | CTD | PMID:30581319 |
Birc5 | Mouse | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of BIRC5 mRNA | CTD | PMID:19465457 |
Birc5 | Mouse | methylseleninic acid | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [2 more ... | CTD | PMID:17876054 and PMID:18444175 |
Birc5 | Mouse | methylseleninic acid | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | methylselenic acid results in decreased expression of BIRC5 mRNA and methylselenic acid results in decreased expression of BIRC5 protein | CTD | PMID:12517777 more ... |
Birc5 | Mouse | miconazole | increases expression | EXP | | 6480464 | Miconazole results in increased expression of BIRC5 mRNA | CTD | PMID:27462272 |
Birc5 | Mouse | mifepristone | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Mifepristone inhibits the reaction [Dexamethasone results in increased expression of BIRC5] | CTD | PMID:21244764 |
Birc5 | Mouse | mitomycin C | increases expression | EXP | | 6480464 | Mitomycin results in increased expression of BIRC5 mRNA and Mitomycin results in increased expression of BIRC5 protein | CTD | PMID:18250050 |
Birc5 | Mouse | mitoxantrone | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Mitoxantrone results in increased expression of BIRC5 protein | CTD | PMID:16638212 |
Birc5 | Mouse | mitoxantrone | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Mitoxantrone affects the expression of BIRC5 mRNA | CTD | PMID:16638212 |
Birc5 | Mouse | MK-2206 | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with MK 2206] results in increased ubiquitination of BIRC5 protein and MK 2206 inhibits the reaction [Epirubicin results in increased expression of BIRC5 protein] | CTD | PMID:35872041 and PMID:36807944 |
Birc5 | Mouse | ML-7 | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | ML 7 results in decreased expression of BIRC5 protein | CTD | PMID:18710790 |
Birc5 | Mouse | monocrotaline | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | Quercetin inhibits the reaction [Monocrotaline results in increased expression of BIRC5 mRNA] | CTD | PMID:25460361 |
Birc5 | Mouse | monocrotaline | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Monocrotaline results in increased expression of BIRC5 mRNA | CTD | PMID:25460361 |
Birc5 | Mouse | monodansylcadaverine | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | monodansylcadaverine results in decreased expression of BIRC5 protein | CTD | PMID:16170020 |
Birc5 | Mouse | morin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | morin results in decreased expression of BIRC5 mRNA | CTD | PMID:28689916 |
Birc5 | Mouse | motexafin gadolinium | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of BIRC5 mRNA] | CTD | PMID:16357179 |
Birc5 | Mouse | motexafin gadolinium | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | motexafin gadolinium results in increased expression of BIRC5 mRNA | CTD | PMID:16357179 |
Birc5 | Mouse | Myrtucommulone A | decreases expression | EXP | | 6480464 | myrtucommulone A results in decreased expression of BIRC5 mRNA | CTD | PMID:26032814 |
Birc5 | Mouse | N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Quercetin results in decreased expression of BIRC5 protein] | CTD | PMID:18377872 |
Birc5 | Mouse | N-acetyl-L-cysteine | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5 more ... | CTD | PMID:21741372 more ... |
Birc5 | Mouse | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | decreases expression | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BIRC5 mRNA | CTD | PMID:25566086 |
Birc5 | Mouse | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Topotecan results in increased degradation of BIRC5 protein] | CTD | PMID:19812371 |
Birc5 | Mouse | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of BIRC5 protein | CTD | PMID:16328441 and PMID:17510429 |
Birc5 | Mouse | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with dihydromyricetin] results in increased ubiquitination of BIRC5 protein more ... | CTD | PMID:17548900 more ... |
Birc5 | Mouse | N-butyl-N-(4-hydroxybutyl)nitrosamine | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | [Butylhydroxybutylnitrosamine co-treated with Propolis analog] results in increased expression of BIRC5 mRNA | CTD | PMID:26111810 |
Birc5 | Mouse | N-methyl-4-phenylpyridinium | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of BIRC5 mRNA | CTD | PMID:24810058 |
Birc5 | Mouse | N-methyl-N-nitrosourea | increases expression | EXP | | 6480464 | Methylnitrosourea results in increased expression of BIRC5 mRNA | CTD | PMID:25270620 |
Birc5 | Mouse | N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of BIRC5 mRNA | CTD | PMID:17854601 |
Birc5 | Mouse | N-nitrosodiethylamine | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Diethylnitrosamine affects the localization of and results in increased expression of BIRC5 protein | CTD | PMID:21776270 |
Birc5 | Mouse | N-nitrosodiethylamine | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Diethylnitrosamine results in increased expression of BIRC5 mRNA and Diethylnitrosamine results in increased expression of BIRC5 protein | CTD | PMID:20514400 |
Birc5 | Mouse | N-nitrosodiethylamine | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BIRC5 mRNA | CTD | PMID:18164116 |
Birc5 | Mouse | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of BIRC5 mRNA more ... | CTD | PMID:17854601 more ... |
Birc5 | Mouse | N-Nitrosopyrrolidine | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in decreased expression of BIRC5 mRNA | CTD | PMID:32234424 |
Birc5 | Mouse | naphthalene | increases expression | EXP | | 6480464 | naphthalene results in increased expression of BIRC5 mRNA | CTD | PMID:18978301 |
Birc5 | Mouse | navitoclax | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [MTOR protein affects the susceptibility to navitoclax] which affects the expression of BIRC5 protein and navitoclax promotes the reaction [Everolimus results in decreased expression of BIRC5 protein] | CTD | PMID:28947240 |
Birc5 | Mouse | navitoclax | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | navitoclax results in decreased expression of BIRC5 protein | CTD | PMID:28947240 |
Birc5 | Mouse | nickel atom | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Quercetin analog co-treated with Nickel] results in decreased expression of BIRC5 protein | CTD | PMID:20577783 |
Birc5 | Mouse | nickel atom | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Nickel results in increased expression of BIRC5 mRNA | CTD | PMID:19031421 and PMID:25583101 |
Birc5 | Mouse | nickel dichloride | affects expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | nickel chloride affects the expression of BIRC5 mRNA | CTD | PMID:22546817 |
Birc5 | Mouse | nickel ferrite | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | nickel ferrite results in decreased expression of BIRC5 mRNA | CTD | PMID:21382431 |
Birc5 | Mouse | nickel sulfate | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | nickel sulfate affects the localization of and results in increased expression of BIRC5 protein | CTD | PMID:21776270 |
Birc5 | Mouse | niclosamide | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Niclosamide affects the expression of BIRC5 protein | CTD | PMID:24552774 |
Birc5 | Mouse | niclosamide | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | enzalutamide promotes the reaction [Niclosamide results in decreased expression of BIRC5 protein] and Niclosamide inhibits the reaction [IL6 protein results in increased expression of BIRC5 protein] | CTD | PMID:25970160 |
Birc5 | Mouse | niclosamide | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Niclosamide analog results in decreased expression of BIRC5 protein more ... | CTD | PMID:24736023 more ... |
Birc5 | Mouse | nicotine | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Curcumin inhibits the reaction [Nicotine results in increased expression of BIRC5 protein] more ... | CTD | PMID:16601104 and PMID:20727180 |
Birc5 | Mouse | nicotine | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Nicotine results in increased expression of BIRC5 mRNA and Nicotine results in increased expression of BIRC5 protein | CTD | PMID:16601104 more ... |
Birc5 | Mouse | nimesulide | decreases expression | ISO | BIRC5 (Homo sapiens) | 127285656 | Nimesulide decreases expression of BIRC5 protein in esophagus squamous epithelium | RGD | |
Birc5 | Mouse | nimesulide | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | nimesulide results in decreased expression of BIRC5 protein | CTD | PMID:16969492 |
Birc5 | Mouse | nimodipine | multiple interactions | EXP | | 6480464 | Nimodipine inhibits the reaction [Dibutyl Phthalate results in decreased expression of BIRC5 protein] | CTD | PMID:33336902 |
Birc5 | Mouse | nitric oxide | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Nitric Oxide results in decreased expression of BIRC5 mRNA | CTD | PMID:15126337 |
Birc5 | Mouse | nitric oxide | decreases expression | EXP | | 6480464 | Nitric Oxide results in decreased expression of BIRC5 protein | CTD | PMID:16166326 |
Birc5 | Mouse | nitroprusside | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Nitroprusside results in decreased expression of BIRC5 protein] more ... | CTD | PMID:14988404 |
Birc5 | Mouse | nitroprusside | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Nitroprusside results in decreased expression of BIRC5 mRNA and Nitroprusside results in decreased expression of BIRC5 protein | CTD | PMID:14988404 |
Birc5 | Mouse | nocodazole | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Nocodazole affects the reaction [BIRC5 protein affects the susceptibility to Melphalan] | CTD | PMID:16373717 |
Birc5 | Mouse | o-anisidine | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | 2-anisidine results in decreased expression of BIRC5 mRNA | CTD | PMID:28089782 |
Birc5 | Mouse | ochratoxin A | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | ochratoxin A results in increased expression of BIRC5 mRNA and ochratoxin A results in increased expression of BIRC5 protein | CTD | PMID:19237604 and PMID:19562491 |
Birc5 | Mouse | ochratoxin A | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | ochratoxin A results in decreased expression of BIRC5 mRNA | CTD | PMID:27193732 |
Birc5 | Mouse | okadaic acid | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of BIRC5 mRNA | CTD | PMID:31115591 |
Birc5 | Mouse | olaparib | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | olaparib results in decreased expression of BIRC5 protein | CTD | PMID:25531448 |
Birc5 | Mouse | oleanolic acid | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Oleanolic Acid results in decreased expression of BIRC5 protein | CTD | PMID:22678527 |
Birc5 | Mouse | oleanolic acid | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Oleanolic Acid results in increased susceptibility to Doxorubicin] which affects the expression of BIRC5 mRNA | CTD | PMID:37345903 |
Birc5 | Mouse | oridonin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | oridonin analog results in decreased expression of BIRC5 protein | CTD | PMID:31594861 |
Birc5 | Mouse | osimertinib | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | osimertinib results in decreased expression of BIRC5 protein | CTD | PMID:36807944 |
Birc5 | Mouse | osthole | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | osthol results in decreased expression of BIRC5 protein | CTD | PMID:31870840 |
Birc5 | Mouse | oxaliplatin | decreases response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein results in decreased susceptibility to oxaliplatin | CTD | PMID:20708607 |
Birc5 | Mouse | oxaliplatin | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of BIRC5 mRNA | CTD | PMID:25729387 |
Birc5 | Mouse | oxaliplatin | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | oxaliplatin results in decreased expression of BIRC5 mRNA | CTD | PMID:25729387 |
Birc5 | Mouse | oxaliplatin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | oxaliplatin results in decreased expression of BIRC5 mRNA and oxaliplatin results in decreased expression of BIRC5 protein | CTD | PMID:16004971 more ... |
Birc5 | Mouse | oxaliplatin | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | oxaliplatin results in increased expression of BIRC5 protein | CTD | PMID:19147571 |
Birc5 | Mouse | oxaliplatin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [oxaliplatin results in decreased expression of BIRC5 protein] more ... | CTD | PMID:16004971 and PMID:20708607 |
Birc5 | Mouse | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of BIRC5 mRNA more ... | CTD | PMID:19555225 more ... |
Birc5 | Mouse | ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of BIRC5 mRNA | CTD | PMID:12763052 and PMID:19555225 |
Birc5 | Mouse | paclitaxel | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Paclitaxel results in increased expression of BIRC5 and Paclitaxel results in increased expression of BIRC5 protein | CTD | PMID:12517802 more ... |
Birc5 | Mouse | paclitaxel | decreases response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein results in decreased susceptibility to Paclitaxel and BIRC5 results in decreased susceptibility to Paclitaxel | CTD | PMID:16202317 and PMID:19133282 |
Birc5 | Mouse | paclitaxel | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Paclitaxel results in decreased expression of BIRC5 mRNA more ... | CTD | PMID:12517802 more ... |
Birc5 | Mouse | paclitaxel | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 4-((3-bromophenyl)amino)-6 more ... | CTD | PMID:16170024 more ... |
Birc5 | Mouse | palbociclib | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | palbociclib results in decreased expression of BIRC5 mRNA | CTD | PMID:22869556 |
Birc5 | Mouse | palmatine | affects binding | ISO | BIRC5 (Homo sapiens) | 6480464 | palmatine binds to BIRC5 promoter | CTD | PMID:17968851 |
Birc5 | Mouse | panobinostat | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Panobinostat results in decreased expression of BIRC5 mRNA | CTD | PMID:30481203 |
Birc5 | Mouse | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of BIRC5 mRNA | CTD | PMID:17942131 |
Birc5 | Mouse | paracetamol | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of BIRC5 mRNA | CTD | PMID:29067470 |
Birc5 | Mouse | paracetamol | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of BIRC5 mRNA | CTD | PMID:22230336 |
Birc5 | Mouse | paracetamol | multiple interactions | EXP | | 6480464 | CAV1 affects the reaction [Acetaminophen results in increased expression of BIRC5 protein] | CTD | PMID:20100502 |
Birc5 | Mouse | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of BIRC5 protein | CTD | PMID:20100502 |
Birc5 | Mouse | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of BIRC5 mRNA | CTD | PMID:26345256 |
Birc5 | Mouse | paraquat | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Paraquat results in decreased expression of BIRC5 mRNA | CTD | PMID:26887261 |
Birc5 | Mouse | PCB138 | multiple interactions | EXP | | 6480464 | 2 more ... | CTD | PMID:25510870 and PMID:29704545 |
Birc5 | Mouse | PD173074 | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [arsenic trioxide results in increased susceptibility to PD 173074] which results in decreased expression of BIRC5 protein | CTD | PMID:27794399 |
Birc5 | Mouse | perfluorononanoic acid | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of BIRC5 mRNA | CTD | PMID:32588087 |
Birc5 | Mouse | perfluorooctane-1-sulfonic acid | affects expression | EXP | | 6480464 | perfluorooctane sulfonic acid affects the expression of BIRC5 mRNA | CTD | PMID:27018151 |
Birc5 | Mouse | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of BIRC5 mRNA | CTD | PMID:36331819 |
Birc5 | Mouse | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | NR1H3 protein affects the reaction [perfluorooctanoic acid results in increased expression of BIRC5 mRNA] | CTD | PMID:25949234 |
Birc5 | Mouse | perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of BIRC5 mRNA | CTD | PMID:36152675 |
Birc5 | Mouse | perfluorooctanoic acid | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of BIRC5 mRNA | CTD | PMID:36326898 |
Birc5 | Mouse | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of BIRC5 mRNA | CTD | PMID:25949234 |
Birc5 | Mouse | phenobarbital | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of BIRC5 mRNA more ... | CTD | PMID:24535843 and PMID:33398415 |
Birc5 | Mouse | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of BIRC5 mRNA | CTD | PMID:19363144 more ... |
Birc5 | Mouse | phenylmercury acetate | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of BIRC5 mRNA | CTD | PMID:26272509 |
Birc5 | Mouse | phenylmercury acetate | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BIRC5 mRNA | CTD | PMID:27188386 |
Birc5 | Mouse | phorbol 13-acetate 12-myristate | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of BIRC5 mRNA | CTD | PMID:19031421 |
Birc5 | Mouse | phytoestrogen | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Phytoestrogens results in increased expression of BIRC5 mRNA | CTD | PMID:18310284 |
Birc5 | Mouse | picoxystrobin | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | picoxystrobin results in increased expression of BIRC5 mRNA | CTD | PMID:33512557 |
Birc5 | Mouse | picropodophyllotoxin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | picropodophyllin results in decreased expression of BIRC5 protein | CTD | PMID:16166596 |
Birc5 | Mouse | pifithrin-alpha hydrobromide | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Topotecan co-treated with pifithrin] results in increased degradation of BIRC5 protein and benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[pifithrin co-treated with Topotecan] results in increased degradation of BIRC5 protein] | CTD | PMID:19812371 |
Birc5 | Mouse | pinosylvin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BIRC5 mRNA | CTD | PMID:23333577 |
Birc5 | Mouse | pirfenidone | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | pirfenidone results in decreased expression of BIRC5 mRNA | CTD | PMID:30481203 |
Birc5 | Mouse | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of BIRC5 mRNA | CTD | PMID:18301758 and PMID:23811191 |
Birc5 | Mouse | piroxicam | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Cisplatin inhibits the reaction [Piroxicam results in increased expression of BIRC5 mRNA] | CTD | PMID:21858171 |
Birc5 | Mouse | piroxicam | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Piroxicam results in increased expression of BIRC5 mRNA | CTD | PMID:21858171 |
Birc5 | Mouse | platycodin D | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | platycodin D results in decreased expression of BIRC5 protein | CTD | PMID:24641402 and PMID:28711525 |
Birc5 | Mouse | platycodin D | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Everolimus promotes the reaction [platycodin D results in decreased expression of BIRC5 protein] and platycodin D promotes the reaction [Everolimus results in decreased expression of BIRC5 protein] | CTD | PMID:28711525 |
Birc5 | Mouse | poly(I:C) | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Poly I-C promotes the reaction [arsenic trioxide results in decreased expression of BIRC5 protein] | CTD | PMID:21418039 |
Birc5 | Mouse | potassium iodide | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Potassium Iodide results in decreased expression of BIRC5 protein | CTD | PMID:32593569 |
Birc5 | Mouse | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of BIRC5 mRNA | CTD | PMID:22698814 and PMID:28903501 |
Birc5 | Mouse | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of BIRC5 mRNA | CTD | PMID:30047161 |
Birc5 | Mouse | pregnenolone 16alpha-carbonitrile | multiple interactions | EXP | | 6480464 | [Phenobarbital co-treated with Pregnenolone Carbonitrile co-treated with Diethylnitrosamine] results in increased expression of BIRC5 mRNA | CTD | PMID:33398415 |
Birc5 | Mouse | prodigiosin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Prodigiosin results in decreased expression of BIRC5 mRNA and Prodigiosin results in decreased expression of BIRC5 protein | CTD | PMID:19133282 |
Birc5 | Mouse | prodigiosin | decreases response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 results in decreased susceptibility to Prodigiosin | CTD | PMID:19133282 |
Birc5 | Mouse | prodigiosin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Prodigiosin inhibits the reaction [Paclitaxel results in increased expression of BIRC5 protein] | CTD | PMID:19133282 |
Birc5 | Mouse | progesterone | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Progesterone results in decreased expression of BIRC5 mRNA | CTD | PMID:21795739 |
Birc5 | Mouse | progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of BIRC5 mRNA | CTD | PMID:21549006 |
Birc5 | Mouse | propanal | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | propionaldehyde results in decreased expression of BIRC5 mRNA | CTD | PMID:26079696 |
Birc5 | Mouse | propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of BIRC5 mRNA | CTD | PMID:21278054 and PMID:25949234 |
Birc5 | Mouse | propylparaben | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | propylparaben results in increased expression of BIRC5 mRNA | CTD | PMID:24481588 |
Birc5 | Mouse | prostaglandin E2 | multiple interactions | EXP | | 6480464 | Dinoprostone inhibits the reaction [[Indomethacin results in decreased activity of PTGS2 protein] which results in decreased expression of BIRC5 protein] | CTD | PMID:21268125 |
Birc5 | Mouse | puerarin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | arsenic trioxide promotes the reaction [puerarin results in decreased expression of BIRC5 mRNA] | CTD | PMID:20416161 |
Birc5 | Mouse | puerarin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | puerarin results in decreased expression of BIRC5 mRNA | CTD | PMID:20416161 |
Birc5 | Mouse | pyrethrins | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Pyrethrins results in decreased expression of BIRC5 mRNA | CTD | PMID:35321623 |
Birc5 | Mouse | pyrimidifen | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | pyrimidifen results in increased expression of BIRC5 mRNA | CTD | PMID:33512557 |
Birc5 | Mouse | pyrrolidine dithiocarbamate | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | pyrrolidine dithiocarbamic acid inhibits the reaction [resveratrol results in increased expression of BIRC5 mRNA] more ... | CTD | PMID:16139439 and PMID:21161674 |
Birc5 | Mouse | pyrrolidine dithiocarbamate | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | pyrrolidine dithiocarbamic acid results in decreased expression of BIRC5 protein | CTD | PMID:29541389 |
Birc5 | Mouse | quercetin | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Quercetin results in increased expression of BIRC5 protein | CTD | PMID:14988404 |
Birc5 | Mouse | quercetin | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | Quercetin inhibits the reaction [Monocrotaline results in increased expression of BIRC5 mRNA] | CTD | PMID:25460361 |
Birc5 | Mouse | quercetin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in decreased expression of BIRC5 protein] more ... | CTD | PMID:16082193 more ... |
Birc5 | Mouse | quercetin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of BIRC5 mRNA and Quercetin results in decreased expression of BIRC5 protein | CTD | PMID:16082193 more ... |
Birc5 | Mouse | quercetin 3-O-beta-D-galactopyranoside | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Quercetin co-treated with hyperoside] results in decreased expression of BIRC5 mRNA and [Quercetin co-treated with hyperoside] results in decreased expression of BIRC5 protein | CTD | PMID:24173369 |
Birc5 | Mouse | rac-1-monopalmitoylglycerol | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | palmitoyl glycerol results in decreased expression of BIRC5 protein | CTD | PMID:37466199 |
Birc5 | Mouse | raloxifene | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Raloxifene Hydrochloride results in decreased expression of BIRC5 protein | CTD | PMID:28430601 |
Birc5 | Mouse | reactive oxygen species | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Sulindac results in increased abundance of Reactive Oxygen Species] which results in decreased expression of BIRC5 protein | CTD | PMID:17136320 |
Birc5 | Mouse | Rebamipide | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | rebamipide results in decreased expression of BIRC5 mRNA and rebamipide results in decreased expression of BIRC5 protein | CTD | PMID:15993841 |
Birc5 | Mouse | reserpine | affects binding | ISO | BIRC5 (Homo sapiens) | 6480464 | Reserpine binds to BIRC5 promoter | CTD | PMID:17968851 |
Birc5 | Mouse | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of BIRC5 mRNA | CTD | PMID:16081268 |
Birc5 | Mouse | resveratrol | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | resveratrol results in decreased expression of BIRC5 mRNA and resveratrol results in decreased expression of BIRC5 protein | CTD | PMID:15763656 more ... |
Birc5 | Mouse | resveratrol | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | resveratrol results in decreased expression of BIRC5 mRNA | CTD | PMID:24092990 |
Birc5 | Mouse | resveratrol | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Resveratrol results in increased expression of BIRC5 mRNA | CTD | PMID:21161674 and PMID:30481203 |
Birc5 | Mouse | resveratrol | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [2 more ... | CTD | PMID:18444175 more ... |
Birc5 | Mouse | resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of BIRC5 mRNA and resveratrol results in decreased expression of BIRC5 protein | CTD | PMID:15837718 more ... |
Birc5 | Mouse | resveratrol | multiple interactions | EXP | | 6480464 | BIRC5 protein affects the reaction [Resveratrol results in increased cleavage of CASP3 protein] more ... | CTD | PMID:15837718 and PMID:22137261 |
Birc5 | Mouse | riboflavin | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Riboflavin affects the expression of BIRC5 | CTD | PMID:20848206 |
Birc5 | Mouse | ritonavir | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Ritonavir results in decreased expression of BIRC5 mRNA and Ritonavir results in decreased expression of BIRC5 protein | CTD | PMID:16174765 and PMID:21270666 |
Birc5 | Mouse | romidepsin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [romidepsin co-treated with Bortezomib] results in increased cleavage of BIRC5 protein | CTD | PMID:18223231 |
Birc5 | Mouse | rosmarinic acid | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | Rosmarinic Acid inhibits the reaction [Malathion results in increased expression of BIRC5 protein] | CTD | PMID:34262720 |
Birc5 | Mouse | rotenone | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Rotenone results in decreased expression of BIRC5 mRNA | CTD | PMID:28374803 |
Birc5 | Mouse | rotenone | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Rotenone results in increased expression of BIRC5 mRNA | CTD | PMID:33512557 |
Birc5 | Mouse | ruxolitinib | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [ruxolitinib co-treated with Arsenic Trioxide] results in decreased expression of BIRC5 mRNA | CTD | PMID:30012499 |
Birc5 | Mouse | Salinomycin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | salinomycin results in decreased expression of BIRC5 protein | CTD | PMID:30273566 |
Birc5 | Mouse | SB 203580 | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | SB 203580 affects the reaction [[gambogic acid co-treated with Doxorubicin] affects the expression of BIRC5 protein] more ... | CTD | PMID:16328441 more ... |
Birc5 | Mouse | SB 203580 | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | SB 203580 results in increased expression of BIRC5 mRNA | CTD | PMID:21165580 |
Birc5 | Mouse | SB 431542 | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BIRC5 mRNA | CTD | PMID:27188386 |
Birc5 | Mouse | sclareol | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | sclareol results in decreased expression of BIRC5 protein | CTD | PMID:37850667 |
Birc5 | Mouse | selenium atom | affects response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein affects the susceptibility to Selenium | CTD | PMID:17876054 |
Birc5 | Mouse | selenium atom | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA] and Selenium analog inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA] | CTD | PMID:27920530 |
Birc5 | Mouse | semilicoisoflavone B | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | semilicoisoflavone B results in decreased expression of BIRC5 protein | CTD | PMID:36901935 |
Birc5 | Mouse | semilicoisoflavone B | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein inhibits the reaction [semilicoisoflavone B results in increased cleavage of CASP3 protein] and BIRC5 protein inhibits the reaction [semilicoisoflavone B results in increased cleavage of PARP1 protein] | CTD | PMID:36901935 |
Birc5 | Mouse | sepantronium | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | sepantronium results in decreased expression of BIRC5 mRNA and sepantronium results in decreased expression of BIRC5 protein | CTD | PMID:23918355 more ... |
Birc5 | Mouse | sepantronium | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 3-methyladenine inhibits the reaction [sepantronium results in decreased expression of BIRC5 protein] more ... | CTD | PMID:24444656 more ... |
Birc5 | Mouse | silibinin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Silybin co-treated with Arsenic Trioxide] results in decreased expression of BIRC5 mRNA | CTD | PMID:21969006 |
Birc5 | Mouse | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of BIRC5 mRNA | CTD | PMID:26345256 and PMID:29341224 |
Birc5 | Mouse | silver atom | decreases expression | EXP | | 6480464 | Silver results in decreased expression of BIRC5 mRNA | CTD | PMID:27131904 |
Birc5 | Mouse | silver(0) | decreases expression | EXP | | 6480464 | Silver results in decreased expression of BIRC5 mRNA | CTD | PMID:27131904 |
Birc5 | Mouse | simvastatin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Simvastatin results in decreased expression of BIRC5 protein] more ... | CTD | PMID:17277159 and PMID:20464445 |
Birc5 | Mouse | simvastatin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Simvastatin results in decreased expression of BIRC5 mRNA and Simvastatin results in decreased expression of BIRC5 protein | CTD | PMID:20464445 |
Birc5 | Mouse | sirolimus | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of BIRC5 mRNA more ... | CTD | PMID:19016759 more ... |
Birc5 | Mouse | sirolimus | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Sirolimus results in decreased expression of BIRC5 protein | CTD | PMID:19931998 and PMID:21601561 |
Birc5 | Mouse | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of BIRC5 mRNA and sodium arsenite results in decreased expression of BIRC5 protein | CTD | PMID:17998272 and PMID:20336670 |
Birc5 | Mouse | sodium arsenite | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | sodium arsenite results in increased expression of BIRC5 mRNA and sodium arsenite results in increased expression of BIRC5 protein | CTD | PMID:32474354 |
Birc5 | Mouse | sodium arsenite | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BIRC5 protein more ... | CTD | PMID:32474354 and PMID:38229313 |
Birc5 | Mouse | sodium arsenite | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | sodium arsenite affects the expression of BIRC5 mRNA | CTD | PMID:29301061 |
Birc5 | Mouse | sodium arsenite | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of BIRC5 mRNA and sodium arsenite results in increased expression of BIRC5 protein | CTD | PMID:14988404 more ... |
Birc5 | Mouse | sodium arsenite | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of BIRC5 mRNA and sodium arsenite results in decreased expression of BIRC5 protein | CTD | PMID:16497974 more ... |
Birc5 | Mouse | sodium arsenite | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [sodium arsenite results in decreased expression of BIRC5] which results in increased activity of CASP3 protein more ... | CTD | PMID:16497974 more ... |
Birc5 | Mouse | sodium fluoride | increases expression | EXP | | 6480464 | Sodium Fluoride results in increased expression of BIRC5 mRNA | CTD | PMID:27862939 |
Birc5 | Mouse | sodium fluoride | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Sodium Fluoride results in decreased expression of BIRC5 mRNA | CTD | PMID:28962382 |
Birc5 | Mouse | sorafenib | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [[[sorafenib results in increased expression of ATF4 protein] which results in increased expression of DDIT4 protein] which results in decreased activity of MTOR protein] which results in decreased expression of BIRC5 protein more ... | CTD | PMID:21601561 and PMID:26911335 |
Birc5 | Mouse | sorafenib | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | sorafenib analog results in decreased expression of BIRC5 protein more ... | CTD | PMID:18200035 more ... |
Birc5 | Mouse | stattic | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | stattic inhibits the reaction [glycine-extended gastrin 17 results in increased expression of BIRC5 mRNA] | CTD | PMID:19153190 |
Birc5 | Mouse | staurosporine | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Staurosporine results in decreased expression of BIRC5 protein | CTD | PMID:16225760 |
Birc5 | Mouse | sulfadimethoxine | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of BIRC5 mRNA | CTD | PMID:30047161 |
Birc5 | Mouse | sulindac | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Sulindac co-treated with arsenic trioxide] results in decreased expression of BIRC5 protein more ... | CTD | PMID:17136320 more ... |
Birc5 | Mouse | sulindac | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Sulindac results in decreased expression of BIRC5 mRNA and Sulindac results in decreased expression of BIRC5 protein | CTD | PMID:11906190 more ... |
Birc5 | Mouse | sunitinib | decreases expression | EXP | | 6480464 | sunitinib results in decreased expression of BIRC5 protein | CTD | PMID:24751611 |
Birc5 | Mouse | sunitinib | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of BIRC5 mRNA | CTD | PMID:31533062 |
Birc5 | Mouse | sunitinib | multiple interactions | EXP | | 6480464 | Chloroquine promotes the reaction [sunitinib results in decreased expression of BIRC5 protein] | CTD | PMID:24751611 |
Birc5 | Mouse | syringin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | syringin results in decreased expression of BIRC5 protein | CTD | PMID:35580997 |
Birc5 | Mouse | tacrolimus hydrate | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Tacrolimus results in decreased expression of BIRC5 mRNA | CTD | PMID:16574167 |
Birc5 | Mouse | tamoxifen | decreases response to substance | ISO | BIRC5 (Homo sapiens) | 6480464 | BIRC5 protein results in decreased susceptibility to Tamoxifen and BIRC5 results in decreased susceptibility to Tamoxifen | CTD | PMID:18815881 |
Birc5 | Mouse | tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of BIRC5 mRNA | CTD | PMID:17555576 |
Birc5 | Mouse | tamoxifen | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Tamoxifen results in decreased expression of BIRC5 mRNA and Tamoxifen results in decreased expression of BIRC5 protein | CTD | PMID:19931998 |
Birc5 | Mouse | tamoxifen | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of BIRC5 mRNA more ... | CTD | PMID:19931998 and PMID:22046442 |
Birc5 | Mouse | Tanshinone I | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | tanshinone results in decreased expression of BIRC5 mRNA | CTD | PMID:21165580 |
Birc5 | Mouse | Tanshinone I | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | SB 203580 inhibits the reaction [tanshinone results in decreased expression of BIRC5 mRNA] and tanshinone inhibits the reaction [Cisplatin results in increased expression of BIRC5 mRNA] | CTD | PMID:21165580 |
Birc5 | Mouse | temozolomide | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | temozolomide results in decreased expression of BIRC5 protein | CTD | PMID:28122345 |
Birc5 | Mouse | temozolomide | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | XAF1 protein promotes the reaction [temozolomide results in decreased expression of BIRC5 protein] | CTD | PMID:28122345 |
Birc5 | Mouse | temozolomide | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of BIRC5 mRNA | CTD | PMID:31758290 |
Birc5 | Mouse | terameprocol | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | terameprocol results in decreased expression of BIRC5 mRNA and terameprocol results in decreased expression of BIRC5 protein | CTD | PMID:15958646 |
Birc5 | Mouse | tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of BIRC5 mRNA | CTD | PMID:15003993 |
Birc5 | Mouse | testosterone | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of BIRC5 mRNA more ... | CTD | PMID:16139439 more ... |
Birc5 | Mouse | testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of BIRC5 protein | CTD | PMID:18030663 |
Birc5 | Mouse | testosterone | multiple interactions | EXP | | 6480464 | gingerol inhibits the reaction [Testosterone results in increased expression of BIRC5 protein] | CTD | PMID:18030663 |
Birc5 | Mouse | testosterone | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of BIRC5 mRNA | CTD | PMID:21592394 |
Birc5 | Mouse | testosterone | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Testosterone results in increased expression of BIRC5 protein | CTD | PMID:18030663 |
Birc5 | Mouse | tetrachloroethene | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Tetrachloroethylene results in increased expression of BIRC5 mRNA | CTD | PMID:19031421 |
Birc5 | Mouse | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of BIRC5 mRNA and Carbon Tetrachloride results in increased expression of BIRC5 protein | CTD | PMID:17484886 more ... |
Birc5 | Mouse | tetrachloromethane | multiple interactions | EXP | | 6480464 | [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of BIRC5 mRNA | CTD | PMID:30517762 |
Birc5 | Mouse | tetraphene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BIRC5 mRNA | CTD | PMID:27858113 |
Birc5 | Mouse | thifluzamide | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | thifluzamide results in increased expression of BIRC5 mRNA | CTD | PMID:33512557 |
Birc5 | Mouse | thimerosal | multiple interactions | EXP | | 6480464 | BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP3 protein] more ... | CTD | PMID:23145070 |
Birc5 | Mouse | thimerosal | decreases expression | EXP | | 6480464 | Thimerosal results in decreased expression of BIRC5 protein | CTD | PMID:23145070 |
Birc5 | Mouse | thioacetamide | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of BIRC5 mRNA | CTD | PMID:23411599 and PMID:34492290 |
Birc5 | Mouse | thiram | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Thiram results in decreased expression of BIRC5 mRNA | CTD | PMID:38568856 |
Birc5 | Mouse | thymoquinone | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | thymoquinone results in decreased expression of BIRC5 protein | CTD | PMID:31433961 and PMID:34627931 |
Birc5 | Mouse | thymoquinone | decreases expression | EXP | | 6480464 | thymoquinone results in decreased expression of BIRC5 protein | CTD | PMID:34605108 |
Birc5 | Mouse | thymoquinone | multiple interactions | EXP | | 6480464 | Doxorubicin promotes the reaction [thymoquinone results in decreased expression of BIRC5 protein] and thymoquinone promotes the reaction [Doxorubicin results in decreased expression of BIRC5 protein] | CTD | PMID:34605108 |
Birc5 | Mouse | thymoquinone | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | thymoquinone inhibits the reaction [Malathion results in increased expression of BIRC5 protein] | CTD | PMID:33510276 |
Birc5 | Mouse | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of BIRC5 mRNA | CTD | PMID:23557971 |
Birc5 | Mouse | titanium dioxide | increases methylation | EXP | | 6480464 | titanium dioxide results in increased methylation of BIRC5 promoter | CTD | PMID:35295148 |
Birc5 | Mouse | titanium dioxide | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | titanium dioxide results in increased expression of BIRC5 mRNA | CTD | PMID:30012374 |
Birc5 | Mouse | titanium dioxide | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Vitallium analog binds to titanium dioxide] which results in decreased expression of BIRC5 mRNA | CTD | PMID:23825117 |
Birc5 | Mouse | tocopherol | increases expression | EXP | | 6480464 | Tocopherols results in increased expression of BIRC5 mRNA | CTD | PMID:17056531 |
Birc5 | Mouse | Tomentosin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | tomentosin results in decreased expression of BIRC5 protein | CTD | PMID:17919456 |
Birc5 | Mouse | topotecan | multiple interactions | ISO | Birc5 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of BIRC5 mRNA | CTD | PMID:25729387 |
Birc5 | Mouse | topotecan | increases degradation | EXP | | 6480464 | Topotecan results in increased degradation of BIRC5 protein | CTD | PMID:19812371 |
Birc5 | Mouse | topotecan | multiple interactions | EXP | | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Topotecan results in increased degradation of BIRC5 protein] and TRP53 inhibits the reaction [Topotecan results in increased degradation of BIRC5 protein] | CTD | PMID:19812371 |
Birc5 | Mouse | topotecan | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Topotecan co-treated with pifithrin] results in increased degradation of BIRC5 protein and benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[pifithrin co-treated with Topotecan] results in increased degradation of BIRC5 protein] | CTD | PMID:19812371 |
Birc5 | Mouse | topotecan | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Topotecan results in decreased expression of BIRC5 mRNA | CTD | PMID:25729387 |
Birc5 | Mouse | trans-pinosylvin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BIRC5 mRNA | CTD | PMID:23333577 |
Birc5 | Mouse | triadimefon | increases expression | EXP | | 6480464 | triadimefon results in increased expression of BIRC5 mRNA | CTD | PMID:25949234 |
Birc5 | Mouse | triadimefon | multiple interactions | EXP | | 6480464 | NR1H3 gene mutant form inhibits the reaction [triadimefon results in increased expression of BIRC5 mRNA] | CTD | PMID:25949234 |
Birc5 | Mouse | Tributyltin oxide | decreases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | bis(tri-n-butyltin)oxide results in decreased expression of BIRC5 mRNA | CTD | PMID:17553608 |
Birc5 | Mouse | Tributyltin oxide | decreases expression | EXP | | 6480464 | bis(tri-n-butyltin)oxide results in decreased expression of BIRC5 mRNA | CTD | PMID:17942131 |
Birc5 | Mouse | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of BIRC5 mRNA | CTD | PMID:25549359 |
Birc5 | Mouse | trichloroethene | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Trichloroethylene results in increased expression of BIRC5 protein | CTD | PMID:34233590 |
Birc5 | Mouse | trichloroethene | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Curcumin inhibits the reaction [Trichloroethylene results in increased expression of BIRC5 protein] | CTD | PMID:34233590 |
Birc5 | Mouse | trichostatin A | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | decitabine inhibits the reaction [trichostatin A results in decreased expression of BIRC5 mRNA] | CTD | PMID:18718068 |
Birc5 | Mouse | trichostatin A | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of BIRC5 mRNA and trichostatin A results in decreased expression of BIRC5 protein | CTD | PMID:18718068 more ... |
Birc5 | Mouse | triclosan | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of BIRC5 mRNA | CTD | PMID:30510588 |
Birc5 | Mouse | trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of BIRC5 mRNA | CTD | PMID:19042947 |
Birc5 | Mouse | troglitazone | affects localization | ISO | BIRC5 (Homo sapiens) | 6480464 | troglitazone affects the localization of BIRC5 protein | CTD | PMID:18407589 |
Birc5 | Mouse | troglitazone | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | troglitazone results in decreased expression of BIRC5 mRNA and troglitazone results in decreased expression of BIRC5 protein | CTD | PMID:16820965 more ... |
Birc5 | Mouse | trovafloxacin | decreases expression | EXP | | 6480464 | trovafloxacin results in decreased expression of BIRC5 mRNA | CTD | PMID:35537566 |
Birc5 | Mouse | tungsten | increases expression | EXP | | 6480464 | Tungsten results in increased expression of BIRC5 mRNA | CTD | PMID:30912803 |
Birc5 | Mouse | tunicamycin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of BIRC5 mRNA | CTD | PMID:29453283 |
Birc5 | Mouse | tyrphostin AG 1478 | multiple interactions | EXP | | 6480464 | [RTKI cpd results in decreased activity of EGFR protein] which results in decreased expression of BIRC5 protein | CTD | PMID:21268125 |
Birc5 | Mouse | tyrphostin AG 1478 | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | RTKI cpd results in decreased expression of BIRC5 protein | CTD | PMID:29974605 |
Birc5 | Mouse | tyrphostin B42 | decreases expression | ISO | BIRC5 (Homo sapiens) | 127285656 | tyrphostin B42 alone or co-treated with Nimesulide decreases expression of BIRC5 protein in esophagus squamous epithelium | RGD | |
Birc5 | Mouse | usnic acid | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | usnic acid results in decreased expression of BIRC5 mRNA | CTD | PMID:32508146 |
Birc5 | Mouse | valproic acid | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of BIRC5 mRNA and Valproic Acid results in decreased expression of BIRC5 protein | CTD | PMID:21771726 and PMID:30481203 |
Birc5 | Mouse | valproic acid | increases expression | ISO | Birc5 (Rattus norvegicus) | 6480464 | Valproic Acid results in increased expression of BIRC5 mRNA | CTD | PMID:35594946 |
Birc5 | Mouse | valproic acid | increases methylation | ISO | BIRC5 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of BIRC5 gene | CTD | PMID:29154799 |
Birc5 | Mouse | valproic acid | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of BIRC5 mRNA | CTD | PMID:25979313 |
Birc5 | Mouse | vemurafenib | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [(+)-JQ1 compound co-treated with vemurafenib] results in decreased expression of BIRC5 mRNA | CTD | PMID:27169980 |
Birc5 | Mouse | venetoclax | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [sepantronium co-treated with venetoclax] results in decreased expression of BIRC5 protein | CTD | PMID:31837377 |
Birc5 | Mouse | verteporfin | multiple interactions | EXP | | 6480464 | Verteporfin inhibits the reaction [1 more ... | CTD | PMID:29893953 |
Birc5 | Mouse | vinyl carbamate | increases expression | EXP | | 6480464 | vinyl carbamate results in increased expression of BIRC5 mRNA | CTD | PMID:17163412 and PMID:17849452 |
Birc5 | Mouse | vitamin E | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | Vitamin E inhibits the reaction [Benzo(a)pyrene results in decreased expression of BIRC5 protein] | CTD | PMID:24664296 |
Birc5 | Mouse | vorinostat | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Sulindac co-treated with Vorinostat] results in decreased expression of BIRC5 mRNA more ... | CTD | PMID:17410615 more ... |
Birc5 | Mouse | vorinostat | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of BIRC5 protein | CTD | PMID:16144943 and PMID:17410615 |
Birc5 | Mouse | vorinostat | affects expression | ISO | BIRC5 (Homo sapiens) | 6480464 | vorinostat affects the expression of BIRC5 protein | CTD | PMID:20846458 |
Birc5 | Mouse | Withanone | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | withanone binds to and results in decreased activity of BIRC5 protein | CTD | PMID:23994265 |
Birc5 | Mouse | wortmannin | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | wortmannin results in decreased expression of BIRC5 mRNA and wortmannin results in decreased expression of BIRC5 protein | CTD | PMID:15065019 |
Birc5 | Mouse | wortmannin | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | wortmannin promotes the reaction [baicalein results in decreased expression of BIRC5 protein] | CTD | PMID:18025287 |
Birc5 | Mouse | wortmannin | decreases expression | EXP | | 6480464 | wortmannin results in decreased expression of BIRC5 protein | CTD | PMID:23145070 |
Birc5 | Mouse | wortmannin | multiple interactions | EXP | | 6480464 | wortmannin promotes the reaction [resveratrol results in decreased expression of BIRC5 protein] | CTD | PMID:22137261 |
Birc5 | Mouse | XMU-MP-1 | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | XMU-MP-1 inhibits the reaction [evodiamine results in decreased expression of BIRC5 protein] | CTD | PMID:32057900 |
Birc5 | Mouse | zearalenone | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Zearalenone results in increased expression of BIRC5 mRNA | CTD | PMID:28965971 |
Birc5 | Mouse | zerumbone | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | zerumbone results in decreased expression of BIRC5 mRNA | CTD | PMID:16007145 and PMID:36122806 |
Birc5 | Mouse | zinc acetate | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Zinc Acetate results in increased expression of BIRC5 mRNA | CTD | PMID:16357179 |
Birc5 | Mouse | zinc acetate | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of BIRC5 mRNA] | CTD | PMID:16357179 |
Birc5 | Mouse | zinc atom | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Zinc deficiency results in increased expression of BIRC5 mRNA | CTD | PMID:22171008 |
Birc5 | Mouse | zinc(0) | increases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | Zinc deficiency results in increased expression of BIRC5 mRNA | CTD | PMID:22171008 |
Birc5 | Mouse | zoledronic acid | multiple interactions | ISO | BIRC5 (Homo sapiens) | 6480464 | [Tretinoin co-treated with zoledronic acid] results in decreased expression of BIRC5 mRNA and [Tretinoin co-treated with zoledronic acid] results in decreased expression of BIRC5 protein | CTD | PMID:20349282 |
Birc5 | Mouse | zoledronic acid | decreases expression | ISO | BIRC5 (Homo sapiens) | 6480464 | zoledronic acid results in decreased expression of BIRC5 mRNA and zoledronic acid results in decreased expression of BIRC5 protein | CTD | PMID:19036117 and PMID:24714768 |